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ENGLISH SUMMARY 
The most frequent reason for referral to the child and adolescent psychiatric hospitals 
in Denmark is the suspicion that a child or an adolescent may have Attention-
Deficit/Hyperactivity Disorder (ADHD) 1. The core-symptoms of this disorder are 
patterns of inattention, hyperactivity, and impulsivity, which are atypical given the 
child’s age 2. Various studies have followed children with ADHD longitudinally into 
adulthood and have found that these children are at risk for obtaining lower 
educational levels, have an increased risk of engaging in criminality, developing 
other psychiatric disorders, and even have higher mortality rates than non-ADHD 
controls 3-9.  
Even though children and adolescents with ADHD share some characteristics with 
respect to their behaviors and level of functioning, they also have different cognitive, 
familiar, and social resources available. According to international studies, these 
individual differences are prognostically relevant, implying that they determine the 
individual child’s risk-profile and to some extent, predict their later outcome  4,6,10-14. 
Even though child and adolescent psychiatric departments are mainly focused on 
treatment of ADHD at presentation, there is also the more far-reaching aim to 
minimize the impact of the diagnosis on the later developmental outcome of the child. 
Therefore, knowledge of the characteristics of Danish children and adolescents with 
ADHD and their family and social background are important and targeting these 
characteristics in treatment and preventive work could prove beneficial.  
A large body of international research has contributed to our knowledge about the 
impact of ADHD across the lifespan, but there is still a need for improving knowledge 
about outcomes and early risk factors. Preceding research in this area has often been 
carried out with small samples, including few females, few studies have investigated 
the course and risk-factors in European (including Danish) children and the 
respective studies often suffer from large attrition rates. Thus, there still is a 
substantial need to expand the knowledge about ADHD across the lifespan especially 
within a Danish context, including the study of how various risk factors modify the 
developmental outcomes of these children.  
Following these principle considerations, the aim of the present PhD dissertation is 
to identify how many individuals received a diagnosis of ADHD in Denmark and 
fulfilled the diagnostic criteria for ADHD, to study the characteristics of these Danish 
children and adolescents with ADHD, and to estimate how many and what kind of 
children with ADHD later engage in criminal behaviors. The dissertation is based on 
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results of five empirical studies, each with specific samples and methods. The 
characteristics of each study will be described in the following before turning to a 
summary of the results. 
Study I: International studies have shown that an increasing number of children, 
adolescents and adults have been diagnosed with and treated for ADHD over the last 
couple of decades 15-22. Since studies have not established whether a similar trend has 
taken place in Denmark, nor identified what the mechanisms behind such time-trends 
could be, the aim of the first study of this thesis was to identify how many children, 
adolescents, and adults were diagnosed with ADHD during the years 1995 to 2010, 
and to identify the underlying mechanisms driving this trend. The study was based 
on data from the Danish Psychiatric Central Research Register (DPCRR) that 
contains information on diagnoses given in Danish psychiatric departments. In 
addition, Danish census data from Statistics Denmark was used 23. 
Study II: In the Danish child- and adolescent psychiatric departments, children and 
adolescents are both assessed and treated for ADHD up to the age of 18. International 
studies have documented that children and adolescents with ADHD often also have 
co-morbid psychiatric disorders 24 . The purpose of this second study was to assess 
the prevalence of comorbid psychiatric disorders among children and adolescents 
diagnosed with ADHD for the first time at age 4-17 years during the years 1995 to 
2010, and to establish whether additional factors such as sex, age, or comorbid 
psychopathology impacted on the prevalence 25. The study was a cross-sectional 
study and like Study I, data from the DPCRR formed the basis of the study.  
Study III: The aim of the third study was to analyze whether the diagnostic criteria 
for ADHD according to the International Classification of Disease 10th version (ICD-
10) were fulfilled for children and adolescents diagnosed with ADHD aged 4 to 15 
years during the years 1995 to 2005. The DPCRR was used to identify children and 
adolescents diagnosed with ADHD during this time-period and medical records from 
a randomly sub-selected sample of these children and adolescents were collected 
from all Danish child and psychiatric departments. The medical records of this sub-
sample were systematically assessed in order to determine if diagnostic criteria for 
ADHD were fulfilled 26. 
Study IV: The fourth study of the present thesis was a systematic literature review 
and meta-analysis that assessed whether ADHD during childhood and adolescence 
was associated with an increased risk for long-term arrest, conviction or 
incarceration. This study informed the design of the fifth study. A systematic quality 
assessment of the included studies analyzed both the strengths and limitations of the 
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preceding research. Studies were identified by conducting systematic searches in the 
databases Pubmed, PsycINFO and Embase 27. 
Study V: The purpose of the last study of the present dissertation was to follow 
Danish children and adolescents diagnosed with ADHD longitudinally and identify 
their risk of conviction and incarceration. The study included data from the ADHD 
sample from Study III and a randomly selected sample of Danish non-ADHD 
children and adolescents. The study used data from many Danish registries including 
the DPCRR, the National Patient Register, the Medical Birth Register, and the Danish 
Crime Register 28.  
In terms of the major results, these five studies found that the number of persons 
diagnosed with ADHD in the Danish psychiatric hospitals had increased during the 
years 1995 to 2010. An increase was observed for both sexes and in all age groups, 
but was especially pronounced among adolescents, adults, and females. Part of the 
increase in first-time diagnosed ADHD was explained by a more general tendency in 
the Danish population to be diagnosed with any psychiatric disorders during these 
years.  
Among children and adolescents with ADHD, diagnoses were based on a solid multi-
informant approach to psychiatric assessment and the majority of patients fulfilled 
the diagnostic criteria for ADHD according to ICD-10 criteria. Furthermore, children 
and adolescents with ADHD often had other comorbid psychiatric disorders and the 
prevalence of comorbid disorders varied according to the sex and age of the child 
with some comorbid disorders increasing the risk of having further mental disorders. 
In addition, children and adolescents with ADHD were identified to more often come 
from socially disadvantaged families.  
The meta-analysis of international studies on crime outcomes showed that children 
and adolescents with ADHD tended to have a two to three-fold risk for being arrested, 
convicted, or incarcerated later in life. This observation was confirmed in Study V, 
but these Danish results also suggested that the risk of conviction associated with 
ADHD was less pronounced than found in previous studies, as some of the observed 
risk could be explained in part, by the presence of psychiatric comorbidity and 
adverse psychosocial backgrounds.  
In sum, the present thesis documents that ADHD is a rather common disorder also in 
Denmark but it was discussed that one may expect that even more individuals will be 
diagnosed in the years to come, as the frequency of diagnosed ADHD was below 
international estimates of the frequency of ADHD in the general population. The 
 VII 
studies document, that despite the fact that children and adolescents with ADHD 
share the same diagnosis, these patients constitute a heterogeneous group with 
different individual, familiar, and social profiles. Although children and adolescents 
have an increased risk for long-term convictions, the risk associated with ADHD may 
be lower than what has been previously assumed. Whereas an important part of the 
association with crime was explained by ADHD, comorbidity and social adversities 
in these children and adolescents also explained some of the association. This 
knowledge should increase the attempts to invest even more strongly into broad 
psycho-social prevention and treatment programs for at-risk patient groups with 
ADHD and their families, in order to reduce the risk of long-term crimes.  
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     DANSK RESUME 
I Danmark er mistanke om ADHD (Attention-Deficit/Hyperactivity Disorder) den 
hyppigste årsag til, at børn og unge henvises til børne- og ungdomspsykiatrien 1. 
Lidelsens kernesymptomer omfatter et mønster af ikke alderssvarende hyperaktivitet, 
impulsivitet og uopmærksomhed 2. Studier, der har fulgt børn med ADHD fra 
barndommen til voksenalderen har bl.a. fundet, at børn med ADHD er i risiko for at 
få mindre uddannelse, har en øget risiko for kriminalitet, og en større risiko for at 
udvikle andre psykiatriske lidelser og sågar også har en øget dødelighed 
sammenlignet med børn og unge uden ADHD 3-9. 
Selvom børn og unge med ADHD har en række fællestræk ift. at dele af deres adfærds 
og funktionsniveau, er børn med ADHD også meget forskellige bl.a. ift., hvilke 
tillægsvanskeligheder de har, samt ift. deres kognitive, familiære og sociale 
ressourcer. Disse individuelle forskelle har i udenlandske studier vist sig at være 
prognostiske  4,6,10-14, dvs. at udsige noget om barnets risikoprofil og senere forløb. 
Selvom arbejdet på de børne- og ungdomspsykiatriske afdelinger søger at afhjælpe 
børn og unge med ADHDs vanskeligheder og symptomer her og nu, er målet også, 
at kunne minimere den indflydelse diagnosen synes at have på barnet og den unges 
livsforløb. Derfor er det essentielt, at vi ved både, hvad der kendetegner danske børn 
og unge med ADHD, men også, hvilke karakteristika hos disse børn og deres familier, 
der kan være vigtige indsatsområder i det forebyggende arbejde.  
En større mængde af international forskning har bidraget til en viden om ADHD i et 
livsforløb, men der mangler forsat meget viden om både forløb og tidlige 
risikofaktorer. Den allerede udførte forskning på området er præget af relativt små 
studier, få studier har fokuseret på piger med ADHD, studierne har ofte et stort frafald 
af studieprobander over tid og meget få studier har undersøgt, forløb og risikofaktorer 
hos europæiske (herunder danske) børn.  
Baseret på disse betragtninger var formålet med indeværende afhandling at 
identificere, hvor mange personer, der i Danmark er diagnosticeret med ADHD og 
hvor mange af de diagnosticerede børn og unge, der opfyldte de diagnostiske kriterier 
for ADHD. Videre sigtede afhandlingen mod at studere, hvad der karakteriserer 
danske børn og unge med ADHD og endeligt at estimere, hvor mange og hvilke børn, 
der senere kommer ud i kriminalitet.  
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Afhandlingen er inddelt i fem studier, med hver deres population og metode. 
Studiernes karakteristika beskrives i de næste afsnit, hvorefter studiernes resultater 
opsummeres. 
Studie I: Internationale studier har vist, at flere børn, unge og voksne de seneste årtier 
er blevet diagnosticeret med og behandlet for ADHD 15-22. Da det ikke har været 
undersøgt om en lignende udvikling har pågået i Danmark og hvad mekanismerne 
har kunne være, var formålet med afhandlingens første studie, at identificere, hvor 
mange børn, unge og voksne, der i årene 1995 til 2010, blev diagnosticeret med 
ADHD og undersøge, om særlige tendenser underlagde udviklingen i perioden. 
Studiet anvendte data fra Dansk Psykiatrisk Central Register (DPCR), der indeholder 
informationer om aktiviteterne på de danske psykiatriske afdelinger, samt census data 
på den danske befolkning fra Danmarks Statistik 23. 
Studie II: På de danske børne- og ungdomspsykiatriske afdelinger udredes og 
behandles danske børn og unge op til 18. leveår for ADHD. Da internationale studier 
har peget på, at børn og unge med ADHD ofte har andre komorbide psykiatriske 
lidelser 24, havde afhandlingens andet studie til formål at undersøge prævalensen af 
komorbiditet blandt førstegangsdiagnosticerede børn og unge med ADHD i alderen 
4 til 17 år, diagnosticeret i 1995 til 2010 og undersøge om prævalensen af psykiatrisk 
komorbiditet var relateret til faktorer såsom, køn, alder og øvrig psykopatologi 25 . 
Studiet var et tværsnitsstudie og anvendte lige som Studie I, data fra DPCR.  
Studie III: Afhandlingens tredje studie havde til formål at undersøge, om børn og 
unge diagnosticeret i alderen 4 til 15 år, i perioden 1995 til 2005 med ADHD også 
opfyldte de diagnostiske kriterier for ADHD jf. Verdenssundhedsorganisationen 
(WHO) International Classification of Disease 10th version (ICD-10). Formålet med 
dette studie var at validere ADHD diagnosen hos denne gruppe af patienter, da disse 
dannede baggrund for afhandlingens femte studie. DPCR blev anvendt til at 
identificere børn og unge diagnosticeret med ADHD i denne periode. Patientjournaler 
for et tilfældigt udsnit af denne gruppe blev indhentet fra de danske børne- og 
ungdomspsykiatriske afdelinger. Informationen fra disse journaler blev systematisk 
gennemgået og vurderet ift. de diagnostiske kriterier for ADHD i ICD-10.  
Studie IV: Afhandlingens fjerde studie var et systematisk litteraturstudie og meta-
analyse, der undersøgte, om ADHD i barne- og ungdomsårene var associeret med en 
øget risiko for senere i livet at blive arresteret, dømt og for at komme i fængsel. Dette 
studie informerede designet af afhandlingens femte studie ved dels at estimere 
risikoen associeret med ADHD, dels ved igennem systematisk kvalitetsvurdering af 
de inkluderede studier, at identificere litteraturens styrker og svagheder. Litteraturen 
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blev identificeret gennem systematisk søgning i databaserne Pubmed, PsycINFO og 
Embase 26. 
Studie V: Afhandlingens sidste studie havde til formål at følge de børn og unge 
diagnosticeret med ADHD, hvis diagnoser blev valideret i Studie III, for at undersøge 
om ADHD også i Danmark er associeret med en øget risiko for at blive dømt og 
fængslet for kriminalitet senere i livet. Studiet sigtede yderligere mod at identificere, 
hvilke risikofaktorer i barne- og ungeårene øgede risikoen for kriminalitet senere i 
livet. Studiet anvendte data fra en lang række danske registre herunder DPCR, 
Landspatientregisteret, det Medicinske Fødselsregister og Dansk Kriminalregister 28.  
Studierne identificerede, at antallet af personer diagnosticeret med ADHD på de 
danske psykiatriske hospitaler har været stigende i perioden 1995-2010. Stigningen 
fandt sted hos begge køn og i alle aldersgrupper, men var særligt udpræget i gruppen 
af unge, voksne og kvinder. En del af stigningen i førstegangsdiagnosticeret ADHD 
kunne forklares af en mere generel tendens, da der samtidigt blev observeret en 
stigning i andelen af befolkningen, der er diagnosticeret med mentale forstyrrelser og 
psykiske lidelser mere overordnet set.  
Blandt børn og unge diagnosticeret med ADHD i perioden 1995 til 2005 fandt vi, at 
diagnoserne ofte var stillet på baggrund af en grundig, multiinformant baseret 
psykiatrisk udredning og, at flertallet af patienter syntes at opfylde de diagnostiske 
kriterier for ADHD jf. ICD-10 kriterierne. Studierne identificerede, at børn og unge 
med ADHD ofte har andre psykiatriske lidelser, og at disse varierer afhængigt af 
udviklingstrin, køn og ift. hvilke psykiatriske lidelser patienten ellers har. Endvidere 
blev det dokumenteret, at børn og unge med ADHD udover at have en ophobning af 
psykiatriske lidelser også oftere kommer fra socialt belastede baggrunde og familier.  
Meta-analysen af tidligere publicerede studier viste, at børn og unge med ADHD 
synes at have en to til tre gange øget risiko for senere i livet at blive arresteret, dømt 
og fængslet for kriminalitet. Denne tendens blev bekræftet i Studie V, der dog pegede 
på, at risikoen associeret med ADHD for senere kriminalitet også delvist kunne 
forklares af faktorer relateret til psykiatrisk komorbiditet og social baggrund.    
Opsummerende viser afhandlingen, at ADHD er en diagnose, der også er relativt 
udbredt i Danmark, selvom det formodentlig må forventes, at flere de kommende år 
vil blive diagnosticeret, da frekvensen af diagnosticeret ADHD i Danmark ligger 
under internationale estimater. Studiet tydeliggør, at selvom børn og unge med 
ADHD har en diagnose tilfælles, udgør disse børn og unge en meget sammensat 
gruppe med forskelligartede individuelle, familiære og sociale profiler. Studiets 
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resultater peger på, at selvom børn og unge med ADHD har en øget risiko for senere 
i livet at komme ud i kriminalitet, så er risikoen forbundet med ADHD mindre end 
hidtidigt antaget. Studierne peger på, at en del af årsagen til, at børn og unge med 
ADHD hyppigere udvikler en kriminel løbebane, dels er relateret til at have ADHD, 
men også er relateret til disse børn og unge har en overhyppighed af 
adfærdsforstyrrelser og sociale risikofaktorer. Denne viden bør styrke vores 
opmærksomhed på, og indsats mod, at forebygge kriminalitet ved at tilbyde særlige 
risikogrupper blandt børn og unge en bred bio-psyko-social indsats og behandling.  
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CHAPTER 1. BACKGROUND 
In Denmark suspicion of Attention-Deficit Hyperactivity Disorder (ADHD) is the 
most frequent reason to refer children and adolescents to the child- and adolescents 
psychiatric hospitals 1. Therefore, it is also critical, that we obtain knowledge about 
ADHD in Danish children and adolescents. The present dissertation is situated in one 
of the most active clinical and research domains of child and adolescent psychiatry 
and psychology, namely, ADHD.  The specific foci of the dissertation are on time 
trends in incidence rates of diagnosed ADHD, validity of the diagnosis, coexisting 
mental disorders, and crime as a major long-term consequence of this disorder 
originating early in life.   
Throughout this dissertation, the term ADHD will be used synonymously with 
Hyperkinetic disorders (HD), as the term ADHD has been used among professionals 
and nonprofessionals both nationally and internationally to characterize this 
phenotype. Whenever referring specifically to differences between HD and ADHD, 
the term HD will however be used.  
 
1.1. THE DEFINITION OF ADHD 
The classification of all mental disorders is based on categorizing various 
psychological and behavioral phenomena existing along a continuum from normal to 
abnormal. If many of a given set of behaviors and psychological traits or experiences 
accumulate in an individual this can be associated with difficulties sustaining and 
maintaining functioning in the society in which this individual is embedded. The 
observable characteristics form what is named a phenotype – a word stemming from 
the Greek words phainein and typos meaning “to show” and “type”.  Thus, the 
classification of mental disorders is different from the classification of many somatic 
conditions since the distinction of the normal and the abnormal is not clear cut, and 
mental disorders are not classified based on their etiology but are phenomenological 
in nature.  
Internationally two diagnostic systems are currently in use, namely, the International 
Classification of Diseases 10th edition (ICD-10) 2 and the Diagnostic and Statistical 
Manual of Mental Disorders 5th  edition (DSM-5)29. Both systems include a 
phenotype characterized by  various cognitive problems including inattentiveness and 
forgetfulness,  excessive hyperactivity and impulsivity. In the ICD-10 this phenotype 
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is called HD whereas the DSM-5 names it ADHD. In both ICD-10 and DSM-5, 
children and adolescents have to present with a minimum of six symptoms of 
inattention. Whereas the ICD-10 have specific cut-off criteria for hyperactivity (at 
least three symptoms) and impulsivity (at least one symptom) separately, the DSM-
5 collapses symptoms of hyperactivity and impulsivity and requires six symptoms in 
this domain.  
Despite great overlap in the diagnostic criteria for HD and ADHD there are various 
differences, including whether clinicians should rate symptoms on three (ICD-10) or 
two domains (DSM-5) as described above. Also, contrary to the ICD-10, in the DSM-
5 clinicians have to specify whether the person has a primarily combined, inattentive 
or hyperactive-impulsive presentation of symptoms 29.  
Also the criteria for the age of onset of when these symptoms have to become 
apparent differ between ICD-10 and DSM-5. According to the ICD-10, the problems 
must become apparent before the age of seven, while the more recent DSM-5 has 
expanded the age of onset criterion to the age of 12. Unlike the definitions in ICD-
10, the symptom cutoff is lowered in the DSM-5 for individuals above the age of 16 
years to accommodate the diagnostic criteria to the developmental changes in 
symptom presentation during the lifespan 30 . In both classifications, it is a 
requirement that symptoms have been present for a minimum of six months and that 
they require symptoms to be present and contribute to substantial impairment in at 
least two developmentally important settings, such as school and family life in 
children and work and romantic relationships in adults.  
ADHD, like other mental disorders, are classified based on symptoms. Although on 
a group level individuals with ADHD can be distinguished on neuropsychological, 
brain anatomical, and functional measures from normal controls, individuals with 
ADHD represent a heterogeneous group and no single abnormality or set of 
abnormalities can be used to distinguish ADHD from non-ADHD with high enough 
sensitivity or specificity 31.  
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1.2. THE HISTORY OF THE CONCEPT OF ADHD 
As with most psychiatric entities, the construct of ADHD has changed over time. The 
first clinical descriptions reminiscent of our current conceptualization of this 
phenotype came from the Scottish physician Sir Alexander Crichton in 1798 who in 
his book “Attention and its Diseases” described the importance of attentional 
functions and the critical outcomes of a disturbed capacity to attend 32: 
“When born with a person [the incapacity of attending] it becomes 
evident at a very early period of life, and has a very bad effect, 
inasmuch as it renders him incapable of attending with constancy to 
any one object of education.”   
“In this disease of attention, if it can with propriety be called so, 
every impression seems to agitate the person, and gives him or her 
an unnatural degree of mental restlessness. People walking up and 
down the room, a slight noise in the same, the moving a table, the 
shutting a door suddenly, a slight excess of heat or of cold, too much 
light, or too little light, all destroy constant attention in such patients, 
inasmuch as it is easily excited by every impression. ….When people 
are affected in this manner, which they very frequently are, they have 
a particular name for the state of their nerves, which is expressive 
enough of their feelings. They say they have the fidgets”. 
Alexander Crichton, 1798 
Later in 1902 the British pediatrician George Frederic Still took the first steps towards 
describing ADHD as a mental disorder. In his lectures he described what he called 
“…an abnormal defect of moral control in children” 33. Moral control was described 
as dependent on three factors: cognitive relation to the environment, moral 
consciousness and volition. He noticed that the defect of moral control was often 
observed in children with intellectual disabilities but he also described 20 cases of 
children with a morbid manifestation of the defect of moral control without 
intellectual impairment or physical disease such as meningitis or cerebral palsy. 
These cases were characterized by a drive towards immediate gratification of 
themselves, without regarding the needs of others or the more “…remote good of 
self” 33.   
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In line with the work by Alexander Crichton, he described children with impairing 
attention problems in the following way: 
“…the case of a boy with moral defect who would repeat the process 
of saying ‘Good-night’ several times before he was aware that he 
had done so; the same boy would often put his boot on the wrong 
foot apparently without noticing it. Another boy, aged six years, with 
marked moral defect was unable to keep his attention even to a game 
for more than a very short time, and, as might be expected, the failure 
of attention was very noticeable at school, with the result that in 
some cases the child was backward in school attainments, although 
in manner and ordinary conversation he appeared as bright and 
intelligent as any child could be.” 
George Frederic Still, 1902 
Later during a global epidemic of encephalitis lethargica that took place from 1917 
to 1928 there was an increasing interest in the organic cause of childhood inattention, 
hyperactivity, and impulsivity known as Postencephalitic behavior disorder. In 1932, 
the German physicians Franz Kramer and Hans Pollow described the condition of 
“Hyperkinetic disease of infancy” marked by motor restlessness, difficulties staying 
on task, and impaired sustained attention. This condition was described with an onset 
before the age of four and as an organic disorder resulting from severe fevers or 
epileptic convulsions 34. These observations, in combination with the identification 
of the therapeutic effects of Benzedrine on the symptoms by Charles Bradley in 1937, 
gave nurture to the development of the concept of Minimal Brain Damage, which 
Rosenfeld and Bradley in 1948 described as 35: 
“…a fairly uniform overt behavior pattern in maladjusted children 
who have experienced asphyxiant illness in infancy. Six cardinal 
behavior characteristics make up this syndrome and may be listed as 
follows: 1. Unpredictable variability in mood; 2. Hypermotility; 3. 
Impulsiveness; 4. Short attention span; 5. Fluctuant ability to recall 
material previously learned; and 6. Conspicuous difficulty with 
arithmetic in school.    
Rosenfeld and Bradley, 1948 
Later on in the 1960’s criticism began to emerge towards the practice of inferring 
brain damage in children with a lack of evidence demonstrating actual neurological 
damage, and so the condition was renamed Minimal Brain Dysfunction (MBD)35. As 
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a consequence, the Oxford International Study Group of Child Neurology re-
conceptualized the hyperkinetic symptoms in terms of functional rather than 
structural abnormalities of the brains of the affected children 35.  
However, as strong correlations between individuals with either brain damage or 
dysfunction and the observed symptoms of hyperactivity were not evident; there was 
a move towards defining the concept on phenomenological rather than aetiological 
grounds. This development was reflected with the introduction of DSM in 1968 by 
re-naming the concept “Hyperkinetic Reaction of Childhood” in DSM-II. In this first 
diagnostic formulation, the symptoms of hyperactivity were very much emphasized 
as core symptoms but the presence of distractibility and short attention span were 
also mentioned 36. In parallel, the ICD-8, published in 1965, also included a 
description of “Hyperkinetic reaction of childhood” emphasizing hyperactivity as 
the core feature 37. The ICD-8 system was in use in Denmark until the introduction 
of the later ICD-10 in 1995. 
Later, in the 1980’s there was a shift towards a stronger emphasis of the attention 
problems seen in hyperactive children. The Canadian Psychological Association 
argued that symptoms of inattention and impulse control were the core-features, 
showing the best response to stimulant treatment, which led to the disorder being 
relabeled “Attention Deficit Disorder with or without Hyperactivity” in DSM-III 38. 
According to DSM-III criteria, hyperactivity was now no longer a critical symptom 
for making the diagnosis but could be either present or absent. This 
reconceptualization differed from the approach in the ICD-9 classification, which 
continued to define hyperactivity as a key feature of the disorder. The ICD-9 was 
never introduced and used in Denmark. 
The introduction of the DSM-III paved the way for the current diagnostic 
classification by defining cut-off scores for symptoms and criteria for age of onset 
and duration of symptoms 39. However, the distinction of ADD with or without 
hyperactivity was soon abandoned in the revised the DSM-III-R, due to the lack of 
an empirical basis for the two subtypes, and the disorder was re-named “Attention 
deficit-Hyperactivity Disorder”. Individuals presenting only with symptoms of 
inattention were now assigned to the category of “Undifferentiated ADD” 40. Based 
on a more solid empirical ground, DSM-IV in 1994 reintroduced the subtyping of 
ADHD after a large field trial had identified two latent classes of symptoms, namely, 
inattention and hyperactivity-impulsivity 41. This led the DSM-IV to now distinguish 
between children with primarily inattention, primarily hyperactive-impulsive 
behaviour or a combined subtype 42.  
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The ICD-10, which was also published in 1994 had an almost identical list of 
symptoms to the DSM-IV but did not leave room for subtyping children with 
“Hyperkinetic Disorders”. Currently, the ICD-10 criteria are still in use 2, while the 
DSM-IV in 2014 was substituted by the DSM-5 29. In this most recent classification, 
the subtyping of ADHD was abandoned again due to the demonstration, that subtypes 
have limited validity 43, and clinicians were instead asked to specify the primary 
symptom presentation. In addition, the age of onset criterion was changed from age 
seven to age 12 and the cut-off symptom criteria were lowered for individuals above 
the age of 16. This change was initiated to make the diagnostic criteria more sensitive 
to the developmental changes in symptom presentation of ADHD later in life 30. 
 
1.3. IMPACT OF DIAGNOSTIC  CLASSIFICATIONS ON 
INDIVIDUALS IDENTIFIED WITH  ADHD 
1.3.1. FROM DSM-II TO DSM-5 
Changing criteria for a disorder results in changing populations defined by this 
disorder. Only a few studies systematically evaluated these consequences in terms of 
case-identification. No studies have looked into the consequences of changing the 
definition from MBD to the DSM-II criteria for Hyperkinetic reaction of childhood. 
One study identified that out of 110 cases diagnosed according to DSM-II criteria, 
only 61 (55.4%) also fulfilled criteria for DSM-III ADD with or without hyperactivity 
44. This finding suggests a relatively poor overlap of DSM-II and DSM-III criteria. 
Furthermore, there was an increase equal to 1.8% in prevalence of cases using DSM-
III compared to DSM-II criteria. Out of the “new” cases, 52% were diagnosed with 
ADD without hyperactivity suggesting that the DSM-III was more sensitive to 
individuals with primarily symptoms of inattention 44.   
 
When the DSM-III was replaced by the DSM-III-R, studies suggested a good overlap 
(90-95%) between the criteria in these two versions. In addition, with the revised 
system (DSM-III-R) an increased number of new cases were identified (7.1-14.4% 
increase in case-identification) 45,46. It was assumed that this increase was related to 
a higher sensitivity to individuals with primarily hyperactive-impulsive symptoms 
and also to those with primarily symptoms of inattention 45,46.  
A strong overlap in case identification amounting to 93-98% was also present when 
the DSM-III-R criteria were replaced by the DSM-IV criteria 41,47,48. The use of DSM-
IV resulted in a 7-15% increase in case-definitions which was primarily related to 
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even higher sensitivity to individuals with the primarily inattentive subtype, to 
females and to adolescents with ADHD 41. In addition, the DSM-IV has been 
described as being more sensitive to less complex cases of ADHD. A comparison of 
cases identified by DSM-III-R criteria and DSM-IV criteria revealed that the new 
cases identified by DSM-IV criteria had less comorbidity of psychiatric disorders, 
such as a lower prevalence of bipolar disorder and conduct disorders 49. Further 
comparisons of the DSM-III and DSM-IV criteria showed that the change in 
diagnostic criteria identified 6.5% more cases with ADHD 49.  
 
Consequences in terms of differences in case-identification have also been studied 
with the recent shift from DSM-IV to DSM-5. In particular, the change in the age of 
onset criteria from age seven in DSM-IV to age 12 years in the DSM-5 has been the 
focus of studies as the ADHD diagnosis was not tested in adult populations during 
the DSM-5 field trials 50. Based on findings from a birth-cohort, it was estimated that 
the change in onset criteria would have minimal impact on prevalence estimates 
among seven to 12 year olds, as only 0.1% of newly identified children and 
adolescents with ADHD reported an onset between the ages of seven to 12 years51. 
However, in adolescents it was established that DSM-IV identified only 7.4% of 
adolescents with ADHD, whereas DSM-5 identified a total of 10.8% 52. This study 
also showed that the clinical features and functional impairment of those with an 
onset between age seven and 12 years was non-significantly different from those with 
an onset before age seven.  
 
A recent Chinese study on self-referred adult individuals found that 22% of 
individuals identified with ADHD had an onset between age seven and 12 years. This 
study identified a decreased quality of life and functional impairment which was 
similar for those with childhood versus late-onset ADHD 53.  Finally, using data from 
the Brazil Pelotas Birth Cohort, DSM-5 criteria identified 27% more adults with 
ADHD at a prevalence of 3.55% using DSM-5 criteria versus 2.8% when using DSM-
IV criteria. This study also supported the validity of lowering the symptom cut-off 
criteria for individuals above the age of 16 to adequately identify individuals with 
substantial impairment 54.  
 
In summary, on the one hand these studies suggest that by each new revision of the 
diagnostic criteria for ADHD the identified population had become larger and more 
heterogeneous, while on the other hand some cases identified by the preceding system 
were not classified as having ADHD in the next. It is likely that the early 
identifications of ADHD by for example, DSM-II criteria contained a rather mixed 
group of individuals with ADHD and other behavioral disorders, whereas the newer 
systems including the most recent DSM-5 criteria are more sensitive to individuals 
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primarily affected by symptoms of inattention, to less complex cases of ADHD, to 
females, to adolescents, and to adults with ADHD. Despite this broadening of the 
identified patient-group there is sufficient evidence that the diagnostic criteria are 
sensitive and specific for individuals with impairment. 
1.3.2. COMPARISON OF DSM-IV AND ICD-10 
So far, studies have not assessed the overlap and differences associated with assessing 
populations using ICD-10 criteria versus DSM-5 criteria. Therefore, the differences 
in case-definitions can only be described for ICD-10/DSM-IV. In The Multimodal 
Treatment Study of Children with ADHD (MTA), a randomized controlled trial of 
children with ADHD assessing the efficacy of various interventions, 579 children 
fulfilling DSM-IV criteria for ADHD were assessed using ICD-10 criteria. Only 25% 
of children (145 out of 579) fulfilled criteria for HD 55.  
 
Similar findings have been identified in a study assessing the predictive validity of 
HD compared to DSM-IV defined ADHD over a six year period of follow-up. In 
N=95 included children aged 4-6 years all meeting DSM-IV - criteria for ADHD, 
only 26% fulfilled criteria for HD 56.  These findings have been used to argue that 
ICD-10 might overlook children with substantial impairment and children at high risk 
of a negative social, educational, and mental health well-being56.  
 
1.4. PREVALENCE OF ADHD 
Due to the historical changes in the concept of ADHD over the last 60 years including 
the differences in classification by either ICD or DSM, it is difficult to arrive at 
reliable estimates of the frequency of ADHD in the population. The most 
comprehensive meta-analysis estimating the point prevalence of ADHD published to 
date included studies that used probalistic sampling strategies in the general 
population under the age of 18, and identified the prevalence of ADHD using the 
criteria provided by either DSM-III, or DSM-III-R, DSM-IV, ICD-9 or ICD-10 57. 
This meta-analysis included 102 studies and arrived at a pooled ADHD point 
prevalence of 5.29% (95% CI=5.01-5.56). The estimated prevalence was higher in 
males than in females (2:1 ratio) and the prevalence was higher in children compared 
to adolescents. The study did not identify differences in prevalence estimates between 
North American and Europe 57.  
For many years it was assumed that ADHD was a childhood disorder. However, using 
prospective longitudinal research designs it has been established that ADHD persists 
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into adolescence and adulthood 30. It was estimated that 15% of childhood ADHD 
cases would continue to meet the full DSM-IV diagnostic criteria for ADHD at age 
25, while 65% would fulfill diagnostic criteria for ADHD in partial remission 58. 
Given this rate of persistence, it was projected that 1.2% of the adult population 
would meet the full set of DSM-IV criteria for ADHD in adulthood and 3.2% would 
fulfill the criteria for ADHD in partial remission 58. Actually, according to the World 
Health Organization World Mental Health Survey Initiative the average prevalence 
of ADHD in adults age 18-44 is 3.4% 59. Thus, ADHD is a relatively common 
psychiatric disorder in the population. There are no large-scale population based 
studies in Denmark that have tested whether the prevalence of ADHD is in 
accordance with the findings from the international literature, but there is no reason 
to suspect that the prevalence should be different in Denmark. 
Despite lacking Danish ADHD prevalence studies, it has become increasingly clear 
in Denmark, as well as in other countries, that an increasing proportion of individuals 
are both diagnosed with and treated for ADHD 15-22. Danish studies provide evidence 
that there are regional differences in the incidence rates of treated and diagnosed 
ADHD 19,60,61, but it is not clear in which subgroups in the population these changes 
have taken place. It is important to identify the number of Danish individuals 
diagnosed with ADHD and to analyse the mechanisms driving the observed increase 
in the number of newly diagnosed individuals to find out whether the observed 
increase is reasonable. In addition, apart from establishing how many individuals are 
diagnosed, it is critical to ascertain whether the diagnosed children and adolescents 
actually fulfil the criteria for ADHD. This issue is highly relevant as a challenge of 
the widely held opinion in the public, the media, and among some professionals that 
ADHD is over-diagnosed.  
1.5. ADHD AND PSYCHIATRIC CO-MORBIDITIES  
As described above in section 1.1, patients with ADHD do not constitute a 
homogenous group of individuals, in terms of their clinical characteristics. 
Comorbidity adds to this heterogeneity and, in fact, multiple studies have provided 
evidence that ADHD often co-occurs with other mental disorders 31,62,63. It is difficult 
to arrive at good estimates of psychiatric comorbidities in ADHD during childhood, 
adolescence and adulthood, as sample definitions can impact on findings. First of all, 
clinical samples or treated samples of children with ADHD tend to have a higher 
frequency of comorbid psychiatric disorders when compared to affected individuals 
in the community 64 because more severe, complex, and chronic cases are likely to 
be referred to psychiatric services. This selection bias, which is known as “the 
clinicians illusion” 65, in turn tends to inflate findings of other comorbid disorders in 
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clinical samples, as the probability of having one disorder, e.g. depression 
significantly increases the risk of other comorbid conditions such as anxiety disorders 
independently of the ADHD status. This phenomenon is known as Berkson`s bias 66.  
Secondly, by applying various sorts of in- and exclusion criteria in defining samples 
of ADHD also the frequency of other psychiatric conditions in the sample will be 
affected. For instance, if one would systematically exclude patients with ADHD and 
co-occurring depression, the prevalence estimates of the co-occurrence with anxiety 
disorders would be affected, as these two disorders are known to co-exist frequently.. 
Whereas internalizing disorders are not often used as exclusion criteria in studies, 
clinical trials and prospective follow-up studies have often systematically excluded 
individuals with autism spectrum disorder (ASD) and intellectual disability (ID)67-69.  
Thirdly, the prevalence of mental disorders co-morbid to ADHD also varies 
according to the temporal definitions of co-existence, for example, whether 
prevalence is estimated during the last six months, during the last year or defined as 
life-time prevalence. Fourthly and finally, because the development of mental 
disorders is sensitive to developmental changes, so is the pattern of psychiatric 
comorbidity seen in patients with ADHD 24. While disorders such as ASD and 
intellectual disability have their onset early in life, other disorders such as depression 
and substance use disorders most frequently have their onset in adolescence and 
adulthood 24. Thus, when inspecting the literature on ADHD and co-morbidity one 
must carefully take into consideration where, when, and how the sample was defined 
and assessed.  
Taking these methodological and developmental considerations into account, both 
community and clinical samples found that the most frequent psychiatric conditions 
comorbid with ADHD are oppositional defiant disorder (ODD) and conduct disorder 
(CD) in childhood and adolescence. In the MTA study assessing the efficacy of 
various treatments on ADHD in N=579 children and adolescents with ADHD in the 
age-range 7 to 9.9 years, 39.9% fulfilled diagnostic criteria for ODD and 14.3% 
fulfilled criteria for the more severe CD70. This finding was corroborated by multiple 
studies with prevalence rates of ODD/CD in the 4 - 60% range 64,71-79.   
The second most frequently observed psychiatric condition in the MTA study at 
baseline was anxiety disorders affecting 33.5% of the sample 70. These findings are 
in line with conclusions from reviews finding that 10 to 35% of children fulfil 
diagnostic criteria for anxiety disorders 24,62,63.  Affective disorders such as depression 
were relatively rare in the MTA sample (3.8%) 70 and have been found to co-exist 
with ADHD to a greater extent later in life 62,63 following the common clinical 
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observation that depression most frequently develops in adolescence and adulthood 
80.  
In the MTA, tic disorders were relatively frequently observed with 10.9% being 
affected 70. However, as the MTA included a clinical trial with methylphenidate 70, 
cases with severe tics or Tourette were excluded and thus, the prevalence of children 
with ADHD and tic disorders most likely was higher. Various other mental disorders 
like e.g. ID were not reported in the MTA study and moderate to severe obsessive 
compulsive disorder (OCD) served as exclusion criteria 70.  
Other studies have found that elimination disorders co-exist with ADHD in 22-32% 
of children 24,81,82. Specific disorders of learning, motor and language development 
have also frequently been observed in ADHD samples with findings in the wide range 
of 10 to 42 % 62,75,76,83-86. The co-occurrence of ADHD with ID and ASD has been 
studied less frequently although children with these conditions are seen quite 
frequently in the clinic. Studies that have looked into the prevalence of ID find that 
between four to 13% of children with ADHD are affected 74,75,87,88  and the prevalence 
of comorbid ASD has been found in 4-10 % of samples 76,89. Later in development, 
there is evidence to suggest that ADHD often co-occurs with personality disorders 
and substance use disorders 24,90-92. 
In summary, the study of the co-occurrence of comorbid disorders in children and 
adolescents with ADHD is complex and findings are depending on when and in 
which samples comorbidity is assessed, and which criteria and definitions are used 
to estimate the prevalence. However, it is clear that many psychiatric conditions such 
as learning disabilities, ODD/CD, ID, ASD are more frequent in children and 
adolescents with ADHD than in normal controls 24. The large overlap of these 
diagnostic entities confer an excess of risk on affected individuals for various adverse 
developmental outcomes which are not nessecarily the result of ADHD alone.  There 
is a need to study a broad range of clinical conditions potentially co-occuring with 
ADHD using large representative samples and studies that look at psychiatric 
comorbidity in a developmentally sensitive way. There is also a need to try to 
deliniate in which subgroups of patients which comorbid disorders tend to aggregate, 
as these may represent meaningful subgroups of patients with different treatment 
needs and different long-term risks and outcomes.  
1.6. COURSE OF ADHD ACROSS THE LIFESPAN 
Various prospective case-control studies have been carried out over the last 50 years 
that have helped to guide our understanding of how children and adolescents with 
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ADHD develop and function in the long term. An overview of selected long-term 
follow-up studies of children and adolescents with ADHD is presented in Table 1 and 
Table 2. Most of these studies have been carried out in the United States of America 
(US), and these studies have primarily followed males with ADHD. A large majority 
of studies recruited clinical samples of children and adolescents with ADHD only 
and most studies systematically excluded individuals with an IQ below 80-85, 
individuals with neurological conditions such as cerebral palsy or epilepsy, and 
children with ASD. The majority of studies used DSM-II-, DSM-III-, and DSM-III-
R-criteria to include individuals with ADHD.   
Only one study from Denmark has performed a long-term follow-up study of a well-
defined cohort of children and adolescents with problems equivalent to ADHD 6. The 
sample consisted of 208 children and adolescents referred to a psychiatric clinic in 
Aarhus during the years 1969 to 1989, who were treated with methylphenidate or 
dexamphetamine. Material from the patient records of these children and adolescents 
were later re-assessed and it was found that 81% fulfilled full or subthreshold DSM-
IV/ICD-10-criteria for ADHD 69.  
This overview clearly shows that longitudinal follow-up studies of children and 
adolescents with ADHD are lacking representativeness to the children and 
adolescents seen in the clinics by for example including few females, and often 
excluding individuals with relatively common psychiatric comorbidities such as ID 
and ASD. In addition, as many studies were initiated when DSM-II-, DSM-III- and 
DSM-III-R-criteria were in use and based on the descriptions in section 1.3.1, it is 
uncertain to what extent the findings generalize from these historical cohorts to 
children and adolescents diagnosed with ADHD nowadays.  
Studying the long-term outcome of children and adolescents with ADHD is rather 
complex, as a range of factors associated with long-term negative outcomes 
accumulate in these samples compared to control children. First of all, ADHD often 
co-exist with other mental disorders, as described in the previous section. Each of 
these psychiatric disorders conveys its own risk on long-term development. In 
addition, children and adolescents with ADHD are more likely to come from low 
SES strata 93 and have parents with psychiatric disorders including ADHD, 
personality disorders and affective disorders 67, each of which are risk-factors for 
adverse psychosocial outcomes.   
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Table 1  Selected follow-up studies of children and adolescents with ADHD 
 
 
Authors Country 
Definition of 
ADHD 
N at baseline 
Percent 
males  
Barkley et al. 
(1990)  12 
Milwaukee, 
USA 
DSM-III-like 
criteria 
ADHD n=158   
Controls n=81 
90.3% 
Biederman et al. 
(1992) 67 
Massachusetts, 
USA 
DSM-III-R ADHD n=140   
Controls n=120 
100% 
Biederman et al. 
(1999) 94 
Massachusetts, 
USA 
DSM-III-R ADHD n=140   
Controls n=122 
0% 
Dalsgaard et al. 
(2001) 69 
Aarhus, 
Denmark 
Inattentive/ 
hyperactive treated 
with stimulants 
ADHD n=208   
Danish 
population 
87% 
Hinshaw et al. 
(2012) 68 
San Fransisco, 
USA 
DSM-IV ADHD n=140   
Controls n=88 
0% 
Mannuzza et al. 
(1989) 11  
New York, USA DSM-II ADHD n=207   
Controls n=100 
100% 
Satterfield et 
al.(1982) 95 
Los Angeles, 
USA 
Hyperactivity, 
impulsivity, poor 
attention span 
ADHD n=204   
Controls n=75 
100% 
Weiss et al. 
(1984) 13 
Montreal, 
Canada 
Restlessness poor 
attention span 
ADHD n=104   
Controls n=45 
92% 
DSM: Diagnostic and Statistical Manual of Mental Disorders   
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Table 2 In and exclusion criteria for cases and controls in selected long-term follow-up studies 
of children and adolescents with ADHD 
Authors Inclusion ADHD  Inclusion controls 
Barkley et al. 
(1990)  12 
Hospital referred children, IQ>80, 
no gross motor or sensory 
abnormalities  
Snowball recruitment method 
among cases, no history of 
mental illness or parental report 
of behavioral problems 
Biederman et al. 
(1992) 67 
Hospital referred children, IQ>80, 
no gross motor or sensory 
abnormalities,  psychosis, autism, 
families from very low SES strata 
excluded  
Recruited from local outpatient 
pediatric clinics 
Biederman et al. 
(1999) 94 
Hospital referred children, IQ>80, 
no gross motor or sensory 
abnormalities,  psychosis, autism, 
families from very low SES strata 
excluded  
Recruited from local outpatient 
pediatric clinics 
Dalsgaard et al. 
(2001) 69 
Hospital referred children, no 
pervasive developmental disorders  
The Danish general population 
used as control group 
Hinshaw et al. 
(2012) 68 
Recruited from schools, hospitals 
and mental health settings. 
Exclusion criteria; intellectual 
disability, pervasive 
developmental disorder, psychosis 
and overt neurological disorder. 
Recruited from same setting as 
ADHD sample but were free of 
ADHD and fulfilled same 
exclusion criteria as ADHD 
sample 
Mannuzza et al. 
(1989) 11  
Hospital referred children, no 
aggressive or serious conduct 
problems, IQ>85, no psychosis or 
neurological disorder 
Recruited from non-psychiatric 
departments seen for minor 
ailments (e.g. influenza) and 
among non-affected siblings of 
ADHD sample 
Satterfield et 
al.(1982) 95 
Hospital referred children, IQ>80, 
no sensory abnormalities, no 
psychosis, attending school 
Recruited from public schools 
and matched to ADHD sample 
on IQ, age and sex. No history of 
psychiatric problems. 
Weiss et al. 
(1984) 13 
Hospital referred children, IQ>85, 
no psychosis epilepsy or cerebral 
palsy 
Recruited from local schools via 
advertisement. No behavioral 
problems, matched to ADHD 
sample on IQ, SES, sex and age 
IQ: Intelligence quotient; SES: socio-economic status 
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1.6.1. PSYCHIATRIC OUTCOMES 
Findings from long-term follow-up studies of children and adolescents with ADHD 
have shown that for many individuals, ADHD has a sizeable long-term impact on 
developmental outcomes. As described earlier, a meta-analysis identified that an 
estimated 15% of children will continue to fulfill diagnostic criteria at age 25, but up 
to 65% will fulfill diagnostic criteria for ADHD in partial remission and continue to 
have functional impairment 58,96. Apart from this finding, long-term follow-up studies 
have also documented an increased risk of developing other psychiatric disorders 
later in life. At the 16 year follow-up point, the Massachusetts study sample had a 
mean age of 27.1 (Standard deviation (SD) 3.3) years and the life-time prevalence of 
mood disorders was approximately 60% in the ADHD sample compared to 20% in 
control subjects. This study found that individuals with ADHD had an increased risk 
of anxiety disorders including agoraphobia, social phobia, OCD and specific phobias 
(65 vs. 40%), antisocial disorders including CD/ODD and antisocial personality 
disorders (APD) (80 vs. 30%) 3. These findings were corroborated by other long-term 
follow-up studies 5,6,97.  
In addition to the findings from the Massachusetts sample, the New York study has 
found an elevated risk of children and adolescents with ADHD for long-term 
substance use problems (56 vs. 38%) when estimating the life-time prevalence of 
mental disorders at age 44 years 5. A significant increased risk of long-term substance 
use disorders 6,14,98, self-harm 68, and various kinds of personality disorders has been 
observed in various samples 92,97. Early predictors of adverse psychiatric outcomes 
have been found to be related specifically to symptoms of CD early in life, which 
increase the likelihood for later APD, and substance use disorders 4,6,10-13. 
1.6.2. EDUCATIONAL AND OCCOPATIONAL OUTCOMES 
Among the various developmental outcomes, the core symptoms of ADHD also have 
an impact on the individual`s capacity to learn and take part in the educational system. 
Long-term outcome studies have shown that children and adolescents in adulthood 
are less likely to graduate from high school, display an increased risk of repeating 
grades and getting detentions, or are expelled from schools and in general, receive 
less years of education than healthy controls 3,8,12,68,99-101. In the Milwaukee studies 
following up participants until age 19-25 years, a total of 42% of the ADHD sample 
compared to 13% of the controls had retained a grade, 60% vs. 18% had been 
suspended during high school, only 68% vs. 100% had graduated high-school, and 
only 15% vs. 76% were still studying at the follow-up assessment 102. In particular, 
the number of symptoms of inattention but also symptoms of hyperactivity 103,104, 
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comorbidity with CD and ODD 8,102,105,106, childhood IQ 100 and family adversity 100 
were predictors of academic achievement.  
In addition to this, long-term outcome studies have shown poorer work-life outcomes 
for adults who had a diagnosis of ADHD in childhood, which has consequences for 
economic independence. These studies demonstrate that adults with a childhood 
diagnosis of ADHD have higher levels of unemployment, are more likely to have 
been laid off or to change jobs multiple times and have lower occupational ranks, 
even after controlling for the impact of other psychiatric disorders comorbid to 
ADHD 3-5,102. Again, in the Milwaukee studies at the follow-up assessment at age 19 
to 25 years, a total of 55% of the individuals with childhood ADHD had experienced 
being fired from a job compared to 23% of the control sample, less had a savings 
account (52 vs. 70%), and more had difficulty saving to pay bills (44 vs. 30%). 
Furthermore, the ADHD sample had changed their occupation more often  than 
controls (Mean= 2.6, SD=2.4 vs. Mean=1.3, SD=1.3), and were also fired from their 
jobs significantly more often. Though not significantly distinguishable at this follow-
up, the ADHD sample had more credit card debt (845 $ vs. 469$), and they owed 
significantly more money to other people (Mean=949$, SD=1210$ vs. Mean=412$, 
SD=502$).   
This study found that the inability to maintain employment was significantly 
associated with employer- rated symptoms of ADHD and self-reported symptoms of 
current ODD. On the contrary, current IQ and severity of childhood ADHD symptom 
severity were not predictive of this outcome. In the same study, severity of childhood 
hyperactivity and employer-reported symptoms of ADHD were significantly 
associated with current job performance 102. In summary, the consequences of these 
educational and occupational outcomes resulted in a lower SES of adults with 
childhood ADHD compared to controls 5. Cross-sectional studies of adults support 
these findings 107,108. 
1.6.3. ANTISOCIAL OUTCOMES 
As children and adolescents with ADHD have been shown to experience a higher 
prevalence of both ODD/CD, APD, and substance use problems, an increased risk of 
antisocial involvement has also been documented in long-term outcome studies. 
Substance use and possession is by itself illegal and many of the symptoms in both 
ICD and DSM for ODD/CD and APD cover behaviors that are directly violations of 
legislations. For example, symptoms like “has stolen”, “has been physically cruel to 
people or animals”, “has used a weapon that can cause serious physical harm to 
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others” or “has forced someone into sexual activity” are among the definitions of 
these disorders 2,29.  
The overrepresentation of individuals with ADHD in crime statistics has been firmly 
established in a recent meta-analysis of prevalence studies of ADHD in incarcerated 
populations, estimating that 30.1% of incarcerated youths and 26.2% of incarcerated 
adults fulfilled diagnostic criteria for ADHD 109. This is equivalent to a five and ten 
fold increase compared to estimations from the general population 109. The fifth paper 
of this dissertation represents a systematic review and meta-analysis of the long-term 
risk of antisocial involvement measured in official arrest records, and thus results 
from this type of studies will be covered later in the dissertation (section 3.4). 
However, a brief overview of the findings from the Milwaukee study will be 
presented below, because it provides an insight into the antisocial involvement that 
had been self-reported by adults. This documentation is reasonable, because the 
review focus is on data from official crime records which typically only detect a 
proportion of all committed criminal acts, since not all antisocial acts come to the 
attention of the law enforcement 110. On the other hand, self-reports on antisocial 
engagement are likely to be influenced by a bias due to underreporting or 
exaggerations 110.  
At the follow-up assessment at age 20 to 21 years, when comparing the ADHD 
sample vs. controls, the Milwaukee study found significant differences on most self-
reported items of antisocial behaviors, except for robbery/mugging (4 vs. 0%), 
forcing someone into sex (1 vs. 0%), sex with a prostitute (2 vs. 0%), illegal drug 
possession (52 vs.42%), and illegal drug sale (24 vs. 20%). The ADHD participants 
reported higher frequencies across all the various antisocial acts compared to control 
participants. Adults with childhood ADHD self-reported that to a larger extent they 
had stolen property (85 vs. 64%), had stolen money (50 vs. 36%), had broken into 
homes (20 vs. 8%), had conducted themselves disorderly (69 vs. 53%), had been in 
fist-fights (74 vs. 52%), had assaulted someone with a weapon (22 vs. 7%), had set 
serious fires (15 vs. 5%), and had carried a concealed weapon (38 vs. 11%). A higher 
number had been arrested at least once (54 vs. 37%), more than twice (39 vs.12%) 
and more than three times (27 vs. 11%) 14.  Despite the antisocial nature of some of 
these behaviours, some seem to be relatively frequent even among typically 
developing individuals, such as having stolen property or money. This study found 
that the presence of ADHD symptoms in childhood, adolescence and adulthood, 
adolescent symptoms of conduct disorder, and adolescent drug use predicted 
engagement in antisocial activities 14.  
ADHD IN DANISH CHILDREN AND ADOLESCENTS 
40
 
In addition, the Los Angeles studies established the finding that adolescent crime 
history predicted adult crime engagement. Younger age at first crime significantly 
increased the risk of repeated offending and parent and teacher reported behaviour 
problems, such as lying or taking money from family members in childhood predicted 
juvenile and adult delinquency, along with lower IQ and lower SES 111,112.   The 
significance of early emerging CD problems and ODD behaviors and low SES as 
predictors for antisocial involvement has also been identified in other studies 113,114. 
However, evidence from the New York studies suggest that childhood behavior 
problems are not the only predictors of adult criminality, as this study excluded 
children with childhood CD 9.  
It is important to note, however, that various factors apart from psychiatric 
comorbidity, are likely operant as early risk-factors for later antisocial involvement 
independent of ADHD exposure. According to a major review of the literature 
published by the Office of Juvenile Justice and Delinquency Prevention from the US 
Department of Justice (2004), these risk-factors operate on various levels ranging 
from individual to familial over societal risk-factors and work in a multiplicative 
fashion to increase the individual`s probability of becoming involved in antisocial 
activities (See Figure 1) 115.  
 
Figure 1 Risk factors for long-term criminality 
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The literature described above clearly indicates that many of these factors are more 
frequently found in children with ADHD and the families of children with ADHD, 
such as an increased risk of lower educational attainment, higher risk of low IQ, CD 
problems, lower family SES, and school expulsions. However, it may be important 
to distinguish between the risk carried by ADHD alone and the risk associated with 
these other factors, in order to gain insight into which risk-factors should be targeted 
in preventive interventions. Therefore, it is also important for studies investigating 
the long-term antisocial risk associated with ADHD exposure to partial out how much 
of the risk is carried by ADHD and how much of the risk is carried by, for example, 
exposure to further familial risk-factors.  Due to the multitude of risk-factors, large 
and detailed data-sets are needed to advance the knowledge about the link between 
ADHD and later antisocial involvement.   
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1.7. AIMS OF THE DISSERTATION 
Based on the review of existing studies on ADHD which are mostly of international 
origin, it becomes evident that there is a great need to study how frequently ADHD 
is diagnosed in Denmark, to analyse data from a large clinical sample of children and 
adolescents with ADHD, to study the mental disorders co-occurring with ADHD and 
to assess the long-term risk of these individuals including the identification of early 
relevant predictors for later antisocial involvement. 
Therefore, the aims of the present dissertation are as follows: 
 First, to identify how often ADHD has been diagnosed in Danish psychiatry 
in the period from 1995 to 2010 in the population age 4 to 65 in the Danish 
Psychiatric Central Research Register (DPCRR), and to identify potential 
underlying time-trends explaining the developments relating to sex, age and 
overall trends in diagnosis of mental disorders.  
 
 Secondly, assess the prevalence of concurrent single and multiple comorbid 
mental disorders in children and adolescents (age 4-17 years) diagnosed 
with ADHD in the DPCRR during the years 1995 to 2010, and to assess if 
age, sex and other comorbidity impacted the prevalence findings  
 
 Thirdly, to assess the validity of the diagnoses of ADHD given to children 
and adolescents in the Danish psychiatric hospitals in the years 1995 to 2005 
ages 4 to 15 years via systematically scoring medical records for the 
presence of ICD-10 criteria for ADHD. 
 
 Fourthly, to systematically review controlled studies with follow ups of 
children and adolescents with ADHD in official crime databases, and to 
synthesize the existing findings in a meta-analysis. 
 
 Fifthly, to follow up the cohort validated in the third study in the Danish 
national crime registry to assess the long-term risk associated with 
childhood ADHD for criminality and to identify early risk and protective 
factors for later conviction.  
Each aim was assessed in individual studies and the methods and results were 
presented in individual papers. In the following two chapters, the methods and results 
of these studies are summarised.  
CHAPTER 2. METHODS 
43 
CHAPTER 2. METHODS 
The present dissertation is based on five studies, which used three different sources 
of data. Study I, II, and V were based on Danish registry data. Study III used a 
combination of register data and data from patient files. Danish register-based studies 
use recorded data from the public and private sectors such as data from the hospitals, 
pharmacies, and the justice system. As this data is recorded for administrative and 
not for research purposes, the number of variables available for research studies are 
limited. However, Denmark fortunately has a long-standing tradition for recording a 
wealth of details on its citizens for many years. The registers are nation-wide, the 
information is generally of high quality, and micro-data is available for institutions 
authorized to handle data by the Danish authorities. Data from the various registries 
can be linked to each other via the unique 10-digit personal identification number 
given to Danish citizens at birth and following them through-out their life 116. 
Therefore, the data can be used to track groups of individuals across registries and 
time and can be organized in a multitude of ways to answer relevant research 
questions. Figure 2 provides an overview of the samples used in the four studies based 
on registry data. Each sample was nested in preceding samples. 
 
 
Figure 2 Sample definitions in Study I, II, III, and V 
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Study IV was a systematic review and meta-analysis. In a systematic review online 
data-bases are searched using predefined strings of search-words to identify relevant 
studies on specific subjects 117. High quality systematic reviews are superior to 
selective reviews because the design is transparent and results reproducible 118,119. 
Results from systematic reviews can be used for meta-analyses where information 
from individual studies identified in the systematic review is extracted, pooled and 
analyzed statistically 117. The advantage of meta-analyses is that via pooling findings 
from individual studies the sample size is increased which improves the statistical 
power and thus the certainty we can have in an estimate.  Study IV was used in the 
planning of Study V by identifying and synthesizing what is already known on the 
topic of antisocial outcomes of ADHD, but also by identifying caveats in the existing 
literature that could be full or partially compensated for in Study V.  
The following section will briefly outline the designs, samples, and statistical 
analyses of each study, along with the rationale for nesting each consecutive sample 
in the preceding. 
2.1. STUDY I 
2.1.1. DESIGN 
The purpose of this study was to identify the number of new cases diagnosed with 
ADHD in Danish psychiatry across the ages 4 to 65 years during the years 1995 to 
2010 per 100,000 inhabitants in Denmark. The analyses were adjusted for sex and 
age and time-trends for the two sexes and the age-groups were identified. An 
additional purpose of the study was to adjust the time trends of diagnosed ADHD for 
the general trends in the population seeking assessment and treatment in Danish 
psychiatric hospitals, in order to elucidate whether the time trends in incidence rates 
of diagnosed ADHD were fully or partially explained by more general societal 
changes.  
2.1.2. DATA SOURCES 
The study used data from the DPCRR. The DPCRR collects data on diagnoses, 
contact dates, and location of the services provided from all public psychiatric 
hospitals. The DPCRR has collected data electronically since 1969 120. The DPCRR 
only started to collect data on outpatient activities from 1995. Data on the number of 
individuals living in the population of Denmark during the observation period was 
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obtained from Statistics Denmark which was used as the denominator to calculate the 
incidence rates per 100,000 person years (PY) and to age- and sex standardise the 
findings. 
2.1.3. SAMPLE 
Incident cases of diagnosed ADHD 
The DPCRR was used to identify all individuals registered with an ICD-10 defined 
(F90.X) or ICD-8 defined (308.3) diagnosis of ADHD. All cases with a first time 
registration of ADHD prior to 1995 in either the ICD-8 or ICD-10 period were 
excluded as the DPCRR only started recording out-patient contacts in 1995.   
Incident cases with any psychiatric disorder 
A first time diagnosis of any psychiatric disorder was also defined using DPCRR data 
and was defined as an individual having an ICD-8 diagnosis of 290.X-315.X or any 
ICD-10 F-diagnosis of substance use disorder (F1X), psychosis or schizophrenia 
(F2X), affective disorder (F3X), anxiety disorder, phobia, OCD or reactions to severe 
stress (F40.X to F43.X), eating disorder (F50.X), ASD (F84), or ODD/CD (F90.X-
F91X). The inclusion and exclusion criteria for the group of individuals diagnosed 
for the first time with any psychiatric disorder were identical to the criteria for the 
ADHD sample.  
The Danish population 
As mentioned above, the denominator was the general Danish population alive and 
aged 4-65 during the years 1995 through to 2010. The number of individuals alive in 
each age group split by sex was obtained for each year from records of Statistic 
Denmark.  
2.1.4. ETHICS 
The study was approved by the Danish Data Protection Agency, the Danish State 
Serum Institute, and Statistics Denmark. 
2.1.5. STATISTICAL ANALYSES 
Incidence rates per 100,000 PY of diagnosed ADHD were calculated and 
standardised for sex and age. For the age-standardisation and identification of time-
trends the following age-strata were formed: preschoolers (age 4-5 years), school-
aged children (age 6 to 12 years), adolescents (age 13 to 17 years), young adults (age 
18 to 29 years), and adults (age 30 to 65 years). In addition to these figures, the 
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incidence rates were adjusted for the general trend for seeking assistance from 
psychiatric services for any psychiatric disorder.  
The time-trends in incidence rates of diagnosed ADHD were assessed by fitting data-
points for each year to linear functions and identifying significant periods of change 
(join-points) during the years 1995 to 2010.  The analyses were run using SPSS 19th 
version 121, Stata 11th version 122, and Joinpoint version 4.0.44 123. 
2.2. STUDY II 
2.2.1. DESIGN 
The aim of Study II was to establish the prevalence of concurrent psychiatric 
disorders in all children and adolescents diagnosed with ADHD (F90.X) in the 
DPCRR using a cross-sectional design. Concurrent psychiatric comorbidity was 
defined as a mental disorder diagnosed in the time periods either three months prior 
to the ADHD diagnosis, at the same date as the ADHD diagnosis, or three months 
after the first time-diagnosis of ADHD (Figure 3).  
 
Figure 3 Definition of concurrent comorbidity 
 
2.2.2. DATA SOURCES 
This study used the DPCRR as the source of information on psychiatric disorder 
concurrently comorbid with ADHD. For a description of the DPCRR see section 
2.1.2.  
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2.2.3. SAMPLE 
In this study, the subset of cases identified as incident cases of ADHD from Study I 
aged 4 to 17 years during the years 1995 to 2010 was selected. The selection criteria 
for this sample are available in section 2.1.3. 
2.2.4. ETHICS 
The study was approved by the Danish Data Protection Agency, the Danish State 
Serum Institute, and Statistics Denmark.   
 
2.2.5. STATISTICAL ANALYSES 
The prevalence of the concurrent psychiatric diagnoses within the ADHD sample was 
calculated for the range of mental disorders displayed in Table 3. Descriptive and 
inferential statistics were used to describe the sample. Mann-Whitney U-tests for 
differences were used to calculate differences among males and females on 
continuous but non-normally distributed data. Chi-square tests were used to test for 
differences among males and females for categorical variables.  
To test whether or not the prevalence of mental disorders differed between the sexes, 
crude and age-adjusted logistic regression analyses were performed to estimate odds-
ratios (OR) with 95% confidence intervals (95% CI) associated with male sex. To 
test whether having one kind of mental disorder significantly increased the risk for 
other mental disorders, logistic regression analyses were used to estimate whether for 
example, comorbid ODD/CD significantly increased the risk of concurrent comorbid 
substance use disorders. Associations among comorbid disorders in the entire sample 
were only investigated in disorders with a prevalence of at least 5% and within strata 
(e.g. ADHD with comorbid ODD/CD) associations were only investigated for 
disorders with a prevalence of at least 2% within this stratum to ensure that enough 
observations were present. These analyses were stratified on sex and controlled for 
age. Analyses were performed using SPSS 19th version 121 and Stata 11th version 122. 
In all tests, the alpha level was set to 0.05.  
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Table 3 ICD-10 definitions of comorbid psychiatric disorder for Study II 
Comorbid disorders by ICD-10 code 
Affective disorders F30-F39 
Anxiety disorders F40–F41, F93.0-F93.2 
Attachment disorders F94.X 
Autism spectrum disorder F84.X (minus F84.2) 
Bipolar disorder F30.X-F31.X 
Conduct disorder/oppositional defiant disorder F90.1, F91.X-F92.X 
Depression F32.X-F33.X, F92.0 
Disorder of language, learning and motor skill development F80.X-F83.X 
Eating disorders F50.X 
Elimination disorders F98.X-F98.12 
Intellectual disability F7X.X 
Obsessive compulsive disorder F42.X 
Personality disorders  F60.X-F62.X 
Reactions to severe stress  F43.X 
Schizophrenia/psychosis F2X.X 
Substance use disorders F1X.X 
Tic disorder/ Tourette syndrome F95.X 
 
2.3. STUDY III 
2.3.1. DESIGN 
The purpose of Study III was to assess whether or not there was sufficient clinical 
data to support the dissertation that children and adolescents age 4 to 15 years 
diagnosed with ADHD in the DPCRR in the years 1995 to 2005 fulfilled the 
diagnostic criteria for this disorder according to ICD-10 criteria. To validate the 
diagnoses in the DPCRR a subsample of those children and adolescents were selected 
and the medical records for these participants were retrieved and scored for the 
presence of symptoms of both ADHD and CD/ODD. All child-and adolescent 
psychiatric clinics in Denmark agreed to participate in the study. To ensure that the 
assessments’ were reliable a subsample were assessed by one of two co-raters, both 
trained clinical child and adolescent psychiatrists, and the degree of agreement was 
calculated. 
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2.3.2. DATA SOURCES 
The DPCRR 120 was used to sample the participants. For the purpose of validating 
the diagnoses, medical records of the random subsample were retrieved. To arrive at 
an impression about the characteristics and functioning of the child or adolescent, a 
broad range of material from the medical records pertinent to the contact leading to 
the first time diagnosis of ADHD of the patient were included.  
All the information was registered in a predefined registration form. The material 
reviewed by the co-raters was blinded for the child’s discharge diagnosis. 
2.3.3. SAMPLE 
As described above, the sample consisted of children and adolescents aged 4 to 15 
years diagnosed with ADHD (F90.X) during the years 1995 to 2005. The reasons for 
studying the validity in this subsample of the entire cohort of children and adolescents 
registered with ADHD in the DPCRR were the following. The decision was made to 
assess the validity of the ADHD in this age-group during those years as the validated 
cohort would be used in longitudinal follow-up studies to study the long-term effect 
of ADHD on development. The decision that children and adolescents could not be 
diagnosed later than age of 15 years to be considered for this study took into 
consideration the fact that the follow-up study (Study V) aimed to follow-up the 
children before they entered their major years at risk for antisocial involvement. As 
the legal age in Denmark is age 15 years, adolescents diagnosed later were excluded. 
Only cases diagnosed during the years 1995 through 2005 were validated to allow 
for sufficient follow-up time of the sample in the outcome study. 
A total of N=4,568 children and adolescents fulfilled the inclusion criteria.  Using the 
formula for sample size determination to estimate a population proportion with 
specified absolute precision, it was decided to randomly select a subsample of 387 
children and adolescents to be part of the validation sample using the formula for 124. 
For the assessment of inter-rater reliability a random subsample  was drawn allowing 
the study to be able to detect a kappa-coefficient (K) of 0.7-0.8 125. To reject the null-
hypothesis (K=0.4) with alpha set a 0.05, at least 68 patients would be needed. As it 
was uncertain how many medical records could be found and included in the inter-
rater reliability assessment, a conservative number of 108 patients were selected. Five 
of these cases were used to establish consensus among raters about the procedures in 
the study and thus, the final inter-rater reliability study included 101 participants.   
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2.3.4. ETHICS 
The study was approved by the Danish Data Protection Agency, the Danish State 
Serum Institute, and the Authority for Patient Safety at the Danish Health and 
Medicines Authority.   
 
2.3.5.  STATISTICAL ANALYSES 
The sample was described using descriptive statistics including counts, percentages, 
means, and SDs. To ascertain the representativeness of the random samples, a series 
of inferential statistics including chi-square tests and independent t-tests were used. 
To ascertain whether any factors predicted poorer validity such as comorbidity of the 
child, year of diagnosis or subtype of ADHD, logistic regression analyses were 
performed calculating ORs with 95% CI. The alpha-level was set at 0.05. To ascertain 
the inter-rater reliability, un-weighted kappas were calculated 126.  Data was analysed 
using SPSS 22nd edition 127. 
 
2.4. STUDY IV 
2.4.1. DESIGN 
The purpose of this study was to assess the long-term risk associated with having 
ADHD in childhood for arrests, convictions, and incarcerations in a systematic 
review and subsequent meta-analysis. To identify studies, electronic databases were 
searched using a range of MeSH, index and free-text words on the 15th of August 
2015 (see section 2.4.2). Studies were selected by one person using an a priori set of 
in- and exclusion criteria.  
The study followed the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement 118. To assess the quality of included studies, the 
Newcastle – Ottawa Quality Assessment Scale Cohort Studies scale (NOS) was used 
128. All included studies were quality assessed by two raters independently of each 
other.  
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2.4.2. DATA SOURCES 
To identify studies, the electronic databases Pubmed, Embase and PsycINFO were 
searched. The following words were used in the search-string: Attention deficit, 
attention deficit hyperactivity disorder, minimal brain dysfunction, hyperkinetic 
syndrome, hyperkinetic disorder, ADHD, DAMP, hyperactive. The databases were 
searched for the following words to identify antisocial outcomes: crim*, incarcerat*, 
imprison*, delinq*, offense*, conviction*, antisocial, arrest, felon*. To limit the 
search to follow-up studies the following words were used in the search string: 
followup, follow up, longitudinal*, outcome*, prognosis, course*, prospectiv*, long 
term. In the search string, no constraints on year of publication, publication type, or 
language were used.  
2.4.3. ETHICS 
As this study included no direct or indirect contact with any human or live beings, no 
ethical or data-protection approvals were needed. 
2.4.4. STATISTICAL ANALYSES 
In the meta-analysis the risk-ratio (RR) and 95% CI associated with childhood 
ADHD for arrests, convictions and incarceration was estimated using random effect 
models. Heterogeneity was assessed using the Cochranes Q-statistic and I2. Results 
from the quality assessment of studies was used as a co-variate in meta-regression to 
estimate whether study quality was significantly related to the estimated risk of arrest, 
conviction, and incarceration. Due to the small number of studies included, 
publication bias was not assessed using funnel-plots but rather by the Classical Fail-
Safe N and Orwins Fail-Safe N to identify how many unpublished studies needed to 
exist in order to change the significance of the findings from the meta-analysis. 
Analyses were performed using the Comprehensive Meta-analysis (2nd ed.) program 
129. 
2.5. STUDY V 
2.5.1. DESIGN 
This study was a longitudinal register-based follow-up study estimating the risk of 
criminality associated with the diagnosis of ADHD in childhood. Apart from 
estimating the prevalence for long-term  arrest, conviction, and incarceration 
associated with a childhood ADHD diagnosis, the aim of the study was to identify 
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adverse and protecting factors associated with long-term conviction. To identify risk-
factors, a range of child, social and family parameters were investigated.   
2.5.2. DATA SOURCES 
Using the Danish Civil Registration (DCR), data from the DPCRR, the Danish 
National Patient Register (DNPR), the Danish Prescription Register (DPR), Danish 
Medical Birth Register (DMBR), The Danish Cause of Death Register (DCDR), and 
data on educational and other background variables from Statistics Denmark were 
linked. The outcome was assessed using the Danish Central Criminal Register 
(DCCR).  
2.5.3. SAMPLE 
Exposed (ADHD) participants were included using the same definitions as in Study 
III. Based on the findings from Study III, individuals diagnosed with F90.8 and F90.9 
were excluded. All exposed participants were matched on date of birth and sex, with 
three to five randomly selected children and adolescents from the general population 
of Denmark who had not previously received a diagnosed of  or been treated for 
ADHD. 
2.5.4. ETHICS 
The study was approved by The Danish Data Protection Agency and The Danish 
Health and Medicines Authority. All information on included individuals was 
anonymised.   
2.5.5. STATISTICAL ANALYSES 
The data was analysed descriptively and by using inferential statistics such as chi-
square analyses and independent samples t-tests. To estimate the risk of long-term 
conviction associated with ADHD exposure, crude and adjusted Cox Proportional 
Hazard models were performed estimating a hazard ratio (HR) and 95% CI. In these 
models, the cohort was followed from date of birth until the outcome of interest 
occurred, the person died, or to the 31st of December 2015. Data were analysed using 
Stata 12th edition 130.  
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CHAPTER 3. SUMMARY OF FINDINGS 
3.1. STUDY I 
During the years 1995 to 2010 in the Danish population aged 4 to 65 years a total of 
20’281 children, adolescents and adults were diagnosed with ADHD for the first 
time. In comparison, a total of 249’607 members of the Danish population were 
diagnosed with any psychiatric disorder.  
During these years  the diagnosed incidence of ADHD increased from 7.3 to 91.2 per 
100.000 PY. Adjusting the incidence rates for the time-trends observed for any 
psychiatric disorder resulted in a less pronounced increase from 7.3 to 53.8 per 
100.000 PY. The Join Point regression analyses suggested that despite the male 
predominance observed for diagnosed ADHD, the increase in incidence rates had 
been more pronounced for females (average annual percent change (APC)= 31.7) 
than in males (APC=20.2). The most pronounced time-trends in diagnosed ADHD 
was seen in young adults (APC=46.3), in adolescents (APC= 29.3), and in adults 
(APC 25.2), while the APC was the least pronounced in preschoolers and school age 
children (for both APC=16.1). This observation remained present, but less 
pronounced, after adjusting the time-trends for the overall increase in the number of 
individuals seen in psychiatry.  
3.2. STUDY II 
In the 14, 825 children and adolescents diagnosed with ADHD for the first time 
during the years from 1995 to 2010, 52.0% had at least one other comorbid 
psychiatric disorder diagnosed concurrently with ADHD, and 26.2% were diagnosed 
with two or more concurrent psychiatric disorders. The most frequently diagnosed 
concurrent psychiatric disorders were ODD/CD (16.5%), specific disorders of 
language, learning and motor development (15.4%), ASD (12.4%), ID (7.9%), tic 
disorders (4.8%) and attachment disorders (4.1%). Substance use disorders, psychotic 
disorders, affective disorders, anxiety disorders, OCD, eating disorders, personality 
disorders, and elimination disorders were diagnosed in less than 2% of the sample.  
When the analyses were adjusted for the age-difference observed between males and 
females, male sex was associated with a significant increased risk of specific 
disorders of language, learning and motor development, ASD, ODD/CD, and tic 
disorders. The risk associated with male sex was significantly decreased for psychotic 
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disorders, affective disorders, anxiety disorders, OCD, reactions to severe stress, 
eating disorders, personality disorders, ID, and attachment disorders.  
The analyses of age at first diagnosis found that the mean age of diagnosed ID, 
specific disorders of language, learning and motor development, ASD, attachment 
disorders, tic disorders, and elimination disorders were before age 10 years in both 
males and females. Psychotic disorders, affective disorders, anxiety disorders, OCD, 
reactions to severe stress, eating disorders, personality disorders, and ODD/CD had 
a mean age of first diagnosis between the ages 10 to 15 years in both sexes, while 
substance use disorders were the only disorders with a mean age at first time 
diagnosis above the age of 15 years.  
Logistic regression analyses revealed that certain disorders tended to aggregate. For 
example, ADHD with comorbid ODD/CD increased the risk of also having co-
occurring substance use disorders, attachment disorders, and elimination disorders in 
both males and females.  
3.3. STUDY III 
Among the children and adolescents diagnosed with ADHD for the first time at age 
4 to 15 years in the period 1995 to 2005 a random sample of 387 was selected for the 
validation study. There were no significant differences between the total sample and 
the randomly selected sample with respect to age, sex, region of diagnosis, year of 
diagnosis, subtype of ADHD, or comorbidity distributions. It was possible to identify 
full or partial medical records for 372 children and adolescents.  
In 93.8% of these 372 files the child’s developmental history was described, in 82.5% 
the child had been subjected to a medical examination, in 96.5% the child had been 
psychologically tested and in 71.2% professional observations had been made of the 
child in for example, the child’s school or kindergarten. In 61.3 % ADHD specific 
questionnaires had been used as part of the assessment, and in 5.9% the child or 
parent of the child had participated in a structured diagnostic interview.  
In 323 of the 372 cases (86.8%) the child was evaluated to fulfill the diagnostic 
criteria for ADHD, while in 30 out of 372 cases (8.1%) a diagnosis could not be 
confirmed. Out of these unconfirmed diagnoses, in 14 cases (3.8% of the sample) the 
diagnosis in the patients discharge letter was incongruent with the diagnosis in the 
DPCRR and thus, represented registration errors. In 16 cases (4.3%) the primary rater 
arrived at a different diagnosis or no diagnosis at all, to what the originally diagnosing 
clinicians had arrived at. Finally, in 19 out of the 372 cases (5.1%) there was too little 
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information in the patient record available to arrive at a conclusion. Year of diagnosis, 
comorbidity, or region of diagnosis, was not significantly related to the odds ratio of 
non-confirmed diagnosis. However, being registered with the F90.9 subtype of 
ADHD increased the odds of non-confirmed diagnoses.  
While the validity of ADHD diagnoses was high in general, it was judged that the 
diagnoses of the subtypes held less validly in those with a confirmed ADHD 
diagnosis. More cases were judged to fulfill criteria for F90.1 in the validation study 
compared to what had been registered in the DPCRR (43.3% versus 15.9%). 
However, among those registered with F90.1 in the DPCRR, 41 out of 59 cases 
(69.5%) could be confirmed in the validation study. Agreement was established 
among raters in 96% of the cases (κ=0.8, p>0.001). 
3.4. STUDY IV 
In the systematic literature search in Pubmed, PsycINFO and Embase 11 studies, 
could be included 9,11,14,111-113,131-136.  These studies covered nine unique, non-
overlapping samples including a total of 15’442 individuals with childhood ADHD 
that had been followed longitudinally. Four of the studies were carried out in the US 
9,14,112,131, one was from Australia 136, one from Sweden 133, one from Finland 134, one 
from China 135, and one was from Denmark 113. The ADHD diagnosis was based on 
DSM-II criteria in two studies 9,134, one cohort was based on DSM-III criteria 112, two 
cohorts were based on DSM-III-R criteria 14,131, and two cohorts were based on DSM-
IV or ICD-10 criteria 135,136. The Danish study was initiated when ICD-8 criteria were 
in use and included only stimulant treated children 113, while the Swedish study had 
used ICD-8, ICD-9, and ICD-10 diagnoses in their follow-up study 133.  
Findings from the meta-analysis revealed that childhood ADHD was associated with 
a significantly higher risk of long-term arrest (RR 2.2, 95% 1.3-3.5), conviction (RR: 
3.3, 95% CI: 2.1-5.2), and incarceration (RR= 2.9, 95% CI 1.9-4.3). For the two 
outcomes of arrest and conviction there was evidence for substantial heterogeneity 
(arrest: I2=58.7; conviction I2=97.2), while the test for heterogeneity was non-
significant for the outcome of incarceration but still the findings were moderately 
inconsistent (I2=28.7). Six out of nine included studies reported on the various type 
of criminal offenses 9,11,113,131,134-136, but as this reporting was not consistent across 
studies, no attempt was made to include these findings in a meta-analysis.  
Individuals with childhood ADHD were most frequently involved in crimes of a 
reactive and impulsive character such as assaults, theft, substance use related crimes, 
and possession of weapons. There was evidence to suggest that ADHD was 
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associated with an earlier age of onset of antisocial involvement and an increased risk 
of recidivism.  
In the quality assessment, the two independent raters agreed on 91.4% of items 
yielding a kappa of 0.7. Study quality was not significantly related to the RR for 
arrest, conviction, or incarceration. The result of the publication bias analyses 
provided evidence that the findings were not substantially affected by publication 
bias.  
3.5. STUDY V 
A total of 3,920 participants with ADHD, 18,031 participants without ADHD and 
data from 21,924 parent pairs were included in the study. At the end of the follow-up 
period, the mean age of exposed was 20.7 years (SD=3.6) and for non-exposed 21.0 
(SD=3.6) years (p=0.804). A total of 79.2% of exposed participants had been treated 
with ADHD medication during the observation period. The exposed participants had 
significantly elevated levels of risk-factors across all background factors. For 
example 30.0 vs. 0.5% had comorbid CD/ODD, an increased number had been placed 
in foster care (8.9 vs. 1.3%), fewer had completed high-school (29.2 vs. 77.0), fewer 
had parents that had lived together for the first ten years of their life (41.3 vs. 68.1%), 
more came from homes with an income below the 50th percentile (64.4 vs. 50.0%), 
and more had either a mother (4.5 vs. 1.7%) or a father (21.1 vs. 10.1%) that had been 
incarcerated during the child’s lifetime.  
Childhood ADHD was associated with a significantly higher prevalence of having 
ever been charged (38.1 vs. 22.5%), convicted (34.4 vs. 19.9%) or incarcerated (17.6 
vs. 6.0%). ADHD exposure was associated with a significantly higher risk of 
committing all types of offenses investigated in the study, except for murder  and 
violation of tax laws. ADHD exposure was associated with having multiple 
convictions (21.5 vs. 8.5%) and incarcerations (10.0 vs. 2.8%).  
The unadjusted risk associated with ADHD exposure for conviction was HR=2.0 
(95% CI=1.9-2.2) and significantly higher for females (HR=3.4, 95% CI=2.7-4.4) 
compared to the estimate for males (HR=2.0, 95% CI=1.9-2.1). After adjusting the 
analyses for the effect of sex, presence of anxiety/depression, ID, ASD, CD/ODD, 
tics/Tourette, birthweight, family income, parent civil status, number of children in 
the household, degree of urbanisation, placements outside the home, parental 
education, parental ADHD, parental psychopathology, parental incarceration and 
parental death, the risk attributed to ADHD dropped to HR=1.5, 95%, CI= 1.3-1.6. 
After rigorous statistical control ADHD exposure in females was still associated with 
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a significantly higher risk of later conviction (Males: HR=1.5, 95% CI= 1.3-1.6, 
Females: HR=2.3, 95%, CI=1.6-3.5).  Male sex, comorbid CD/ODD, parental 
separation, the number of children in the household, placements outside the home, an 
income below the 50th percentile, parental psychopathology, having parents that had 
not completed formal education, parental incarceration and parental death 
significantly increased the risk of conviction. Comorbid ASD, ID, and actively taking 
ADHD medication, reduced the risk of conviction significantly.  
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CHAPTER 4. DISCUSSION 
The overarching aim of this dissertation was to enhance our knowledge of children 
diagnosed with ADHD and treated in Danish child and adolescent psychiatry. First, 
the analyses revealed that during recent years ADHD had been increasingly 
diagnosed across both sex and all age groups (Study I). Secondly, psychiatric 
comorbidity was frequent in children and adolescents with ADHD (Study II) and in 
comparison to children and adolescents without ADHD (Study V), those affected by 
ADHD were more likely to have comorbid psychiatric disorders and an aggregation 
of psychosocial risk factors (Study V). The individual risk of a patient for a given 
psychiatric comorbid disorder was related to the age and sex of the child, and certain 
comorbid psychiatric disorders tended to aggregate with each other (Study II).  
Among children and adolescents with a registered diagnosis in the DPCRR it was 
found that a diagnosis of ADHD could be confirmed in the majority of the cases 
registered with ICD-10 – diagnoses F90.0 and F90.1 but also that comorbid ODD 
and CD may have been underdiagnosed in this population (Study III). The result of 
the systematic review and meta-analysis provided evidence that ADHD is associated 
with a two to three fold long-term risk for arrest, conviction, and incarceration, but 
the study also revealed important limitations in the existing body of research in this 
area (Study IV). The long-term follow-up study of children and adolescents with and 
without ADHD in the national, Danish registries confirmed the finding of an 
increased risk for crimes in association with ADHD, and extended the existing 
knowledge by identifying clinically relevant and early manifesting risk and protective 
factors associated with long-term conviction (Study V).  
In the following sections, the findings from Study I-V and their implications will be 
discussed and in closing, the limitations of these studies will be described. 
4.1. DIAGNOSED ADHD IN THE DANISH POPULATION 
Study I found that a total of 20, 281 individuals in the age-range 4 to 65 years and 
alive in 1995 to 2010 were diagnosed with ADHD in Danish public psychiatric 
hospitals 23. Similar to findings from other studies 15-18,21,22, the findings showed that 
the number of participants diagnosed or treated with ADHD has risen continuously 
over the last 16 years in Denmark. These general observations have attracted the 
attention of both Danish and international media and there have been speculations 
that either ADHD may have become an over-diagnosed disorder, or that more 
individuals than ever are developing ADHD. As the findings from Study I are merely 
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calculations of the number of new persons that are diagnosed for the first time with 
ADHD for each year, the study cannot make claims about causation or clearly explain 
the exact causes of why we have witnessed these trends.  
However, the findings from Study I can be compared to the knowledge compiled 
from previously conducted studies on this topic allowing us to ascertain whether the 
incidence rates of diagnosed ADHD in Denmark are similar to findings from other 
countries. As only one other study, based on Taiwanese data, 16 on incidence rates of 
diagnosed ADHD has been carried out world-wide, comparisons are hampered. An 
alternative approach is then, to express the results of Study I differently, as a life-time 
risk of diagnosed ADHD, as it would allow for cautious comparison with studies 
assessing the life-time prevalence of ADHD.  The children born in 1995 were the 
first birth-cohort in the dataset with complete follow-up data available in the ICD-10 
period and will here be used as an example. According to census data from Statistics 
Denmark, 69,771 children were live born in 1995. In 2010, when the 1995 birth-
cohort was aged 15 years, a total of 1,132 had been diagnosed with ADHD according 
to data from the DPCRR. If one assumes that all members of the 1995 birth-cohort 
were alive at age 15 years in 2010, this would result in an administrative life-time 
risk at this age of 1.6% diagnosed ADHD.  
The US-American National Comorbidity Survey-Adolescents Supplements (NCS-A) 
investigated the life-time prevalence of mental disorders using the World Health 
Organization Composite International Diagnostic Interview (CIDI) in a 
representative community sample of adolescents aged 13 to 18 years in a total of  
10,123 participants and found a life-time prevalence of ADHD of 8.6% among 
adolescents age 15 to 16 years 137. Although life-time prevalence and life-time risk 
are not completely identical measures these can with some assumptions be compared, 
and by comparing the two estimates it becomes clear that the life-time risk of 
diagnosed ADHD in the Danish 1995 birth-cohort was rather low. Thus, despite an 
increasing incidence rate of diagnosed ADHD in the Danish population in the years 
1995 to 2010 there is no direct evidence to support the notion that ADHD is over-
diagnosed, at least not up to the end of the study in 2010. However, one cannot 
ascertain whether further participants with ADHD may have been diagnosed outside 
the public psychiatric hospitals, as privately practicing doctors are exempted from 
reporting to the DPCRR. However, at least within the public psychiatric system, the 
increasing rates of diagnosed ADHD more readily point towards a trend of increasing 
rates of diagnosed ADHD which may be due to improved recognition rather than 
over-diagnosis. Perhaps even more importantly, the results may also suggest that a 
substantial proportion of the Danish population of all ages may have undetected 
ADHD.    
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The other concern mentioned in this context was the notion of whether the observed 
time-trends can be interpreted as the result of a rising number of people developing 
ADHD. The results from Study I do not provide an answer to this question because 
data from the DPCRR can only be used to measure the frequency of diagnosed 
ADHD. If one wishes to gain knowledge about changing rates of ADHD in the 
Danish population, one would need solid population-based estimates of how frequent 
ADHD is in the population, independently of whether the condition has been 
diagnosed or not, and additional follow-up analyses could then assess whether the 
prevalence has truly changed over time. Such an approach can only be done by using 
other research designs where screening and/or a systematic diagnostic assessment of 
ADHD in representative population-based samples is carried out, as many factors 
such as better knowledge or recognition of ADHD may contribute to changes in how 
many affected participants are diagnosed, and therefore registered in the DPCRR. 
However, a recent meta-analysis of 135 studies carried out over three decades 
concludes that there is no data to suggest that more individuals are affected today by 
ADHD compared to 20 years ago 138. This study identified some variation in findings 
but most of the observed variation was explained by methodological differences in 
studies, such as changes in the diagnostic criteria for ADHD 138.  
As the present study only looked at diagnosed ADHD in the Danish ICD-10 period, 
the increase in diagnosed ADHD cannot be directly explained as a consequence of 
changed classification systems as was observed in the aforementioned meta-analysis. 
However, it may still be reasonable to interpret the increased incidence rates of 
diagnosed ADHD in Study I, at least to some extent, as a result of better recognition 
of ADHD in Denmark. This may have resulted from changing the diagnostic 
classification from ICD-8 to ICD-10 in 1994. Before 1994, a formal clinical 
description of ADHD did not exist in the nomenclature used in the clinics. A 
diagnosis of Hyperkinetic reaction in childhood was listed in the ICD-8 but without 
specifying any criteria for the condition. This background scenario may have been 
particularly relevant for explaining the increases in incidence rates observed for 
adolescents and adults. It may well be that among those who were adolescents and 
adults in the observation period 1995-2010, problems of inattention, hyperactivity, 
and impulsivity may have been overlooked when these participants were still in their 
childhood years due to the absence of appropriate diagnostic descriptions.  
Furthermore, the study found that the time-trends in incidence rates of diagnosed 
ADHD was more pronounced in females compared to males, suggesting that ADHD 
may also have been overlooked in females. Although it is not a new finding that 
females may suffer from ADHD, the ADHD child prototype for many years was of 
a male child. However, as knowledge about ADHD in females has improved during 
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the recent years and organizations such as the Danish ADHD Association have done 
a lot of work on raising awareness of ADHD in females, these changes may 
ultimately have lead to less biased referral patterns for the two sexes, and contributed 
to the time-trends observed in Study I.  Improved knowledge about ADHD and 
mental health problems in the general population may also help to explain the 
increase in incidence rates of diagnosed ADHD in terms of more people seeking help 
for psychiatric assessment and treatment. A German survey with assessments at two 
time-points with an eight year interval has for instance, found that mental health 
literacy has increased over time  139.  
Thus, one may conclude that a major part of the increase in incidence rates observed 
in Study I may be explained by the concequences of introducing a new diagnostic 
criteria in 1994, and by the improved knowlegde about ADHD and perhaps mental 
disorders in general in Denmark. It is a well-known finding from epidemiological 
studies on incidence rates of cancer that new knowlegde and new techiques affect 
disease detection rates. For example, the introduction of new population-based 
screening techniques has been known to cause a rapid increase in incidence rates of 
diagnosed cancer, which later declined again once the bulk of unidentified cases 
became identified 140. However, it is uncertain whether or not one may also expect 
such a drop in incidence rates in diagnosed ADHD in near future. Contrary to the 
systematic screening employed in cancer detection programs, ADHD is not a 
systematically screened diagnosis in the population leading to a much slower 
identification of previously unidentified cases. As our interpretation of the results 
indicated there may still be many unidentified individuals with ADHD in the Danish 
population, and therefore the numbers of diagnosed individuals may continue to 
increase in the years to come. Although the present findings cannot rule out the 
possibility that ADHD or other mental disorders are not affecting an increasing part 
of the population, it is rather unlikely that any risk-factor could affect such specific 
segments of the population in such a short time that it might explain the time-trends 
observed in Study I.    
From this discussion it becomes evident that the results from Study I cannot provide 
precise estimates of the frequency of ADHD in the Danish population nor can the 
study be used to assess the exact causes bringing about the significant time-trends 
observed in the study. However, one may conclude that register-based studies such 
as Study I can be thought of as a useful tool for surveillance that can help researchers 
and mental health providers. Such surveillance can be crucial for detection of social 
groups that for some reason do not seem to reach psychiatric services, and the 
discussion of specific data may moderate the public concern about for instance an 
over-diagnosis. In addition, studies like Study I can give politicians and service 
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providers a hint about how services will need to adapt and to whom, to ensure that 
adequate resources are available and that enough professionals are trained to help 
individuals in need of treatment or other assistance.  
However, although ensuring that the correct number of people are receiving treatment 
from psychiatric service is important, ensuring that the correct individuals are 
diagnosed is another issue. Although it is critical for patients and their families that 
the diagnosis is correct, the correctness of diagnoses is also important for research 
studies using information about diagnoses from registries such as the DPCRR as the 
basis for studies. Therefore, it is also critical that apart from monitoring the number 
of individuals receiving treatment, resources are also invested into validating the 
diagnoses, as was the aim of Study III. This study found that the diagnosis of ADHD 
among children and adolescents aged 4 to 15 years and diagnosed for the first time 
with ADHD in 1995 to 2005 had a high degree of validity. In 87% of the assessed 
medical records the descriptions of the child were in accordance with ICD-10 criteria 
for ADHD and there was no effect of year or region of diagnosis on the quality of the 
diagnoses. The only factor that significantly predicted an increased risk of not 
fulfilling diagnostic criteria was if the child was registered with unspecified ADHD 
(F90.9) in the DPCRR. This finding makes sense as this diagnosis is usually given as 
a preliminary referral diagnosis only to later be substituted by a more specific 
diagnosis or no diagnosis at all.  
Therefore, the recommendation following these findings was to exclude cases with 
F90.9 from any future registry based studies of children and adolescents with ADHD 
when using the DPCRR, as done in Study V. In addition, the results of Study III 
determined that the presence of symptoms of ADHD and the derived diagnosis could 
be reliably established since the primary rater and the co-raters agreed in 96% of the 
cases included in the reliability study. Another important finding in the validation 
study was that there was evidence to suggest that the subtype Hyperkinetic conduct 
disorder had been underdiagnosed in the clinics. This finding is of great importance 
for the interpretation of the findings of both Study II and Study V, and will be 
discussed later (section 4.4.5). Unfortunately Study III did not assess the validity of 
registrations for other psychiatric disorders among children and adolescents 
diagnosed with ADHD in the DPCRR. 
4.2. THE LONG-TERM ANTISOCIAL OUTCOME OF ADHD 
The results of the systematic review and meta-analysis in Study IV provided evidence 
that childhood ADHD was associated with a two to three fold risk for being arrested, 
convicted, and ultimately incarcerated due to engagement in criminal activities. 
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However, although these analyses provided strong evidence to support the hypothesis 
of an increased long-term risk for getting involved in criminality associated with 
childhood ADHD, the systematic appraisal and quality assessment of studies also 
identified some potential limitations in the existing literature related to 
methodological issues and representativeness of samples. These issues will be the 
focus of the next paragraphs and will also highlight the complexity of studying the 
long-term antisocial outcome associated with ADHD. 
The quality assessment of studies in Study IV found that many studies had not been 
well-controlled or attempted to match for the effects of what Study IV considered 
key confounders, namely, the effect of age, sex or SES. However, as discussed in the 
back-ground section of this dissertation also other factors are known to increase the 
risk of long-term criminality (section 1.6.3), and as most studies included in Study 
IV included less than 300 participants, the samples have not been sufficiently large 
to allow for statistical control of a sufficiently large number of potential confounders, 
including presence of psychiatric comorbidity and differences in social and family 
backgrounds of children and adolescents with and without ADHD. 
The importance of such methodological control in outcome studies becomes clear 
when we consider the heterogeneity of samples of ADHD which was evident from 
the results of Study II and Study V. Study II found that 52% of children and 
adolescents aged 4 to 17 years had at least one other psychiatric comorbidity 
diagnosed at the time of their first assessment of ADHD and that the rates of 
comorbidity differed according to the age and sex of the child. Moreover, Study II 
revealed that the risk of one comorbid psychiatric disorder was dependent on the 
presence of other disorders and as such the risk was not evenly distributed in the 
sample.  
Furthermore, the findings from Study V highlighted the heterogeneity of ADHD 
samples in terms of the social and family background of these children and 
adolescents. These findings indicate that children and adolescents with ADHD are 
just as different from each other on many variables as children and adolescents are in 
general, but the findings also show that various risk-factors are aggregated in this 
population. These characteristics highlight the difficulties emerging from the study 
of long-term outcomes of childhood ADHD, as these children and adolescents 
experience an accumulation of risk-factors, which are predictive of adverse 
developmental outcomes. For example, independent of ADHD there is a well-known 
association between low birthweight and the long-term risk for receiving less 
education 141, and an increased risk of incarceration or substance abuse associated 
with childhood CD 142,143. Therefore, when studying the outcome of ADHD, one 
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should ensure that large data-sets with relatively detailed data are used, such as the 
dataset used in Study V, to allow an adequate control for the presence of at least a 
matrix of common and well-known risk-factors and the age and sex of the child needs 
to be taken into consideration as well. Such a procedure is necessary if one wants to 
address with more certainty which kind of risk of criminality is specifically related 
to ADHD. One could argue that such an endeavor is artificial as the clinical reality, 
as documented in Study II and V, is marked by complexity, but then again it is 
important to partial out what factors cause which outcomes, if we want to identify 
meaningful subgroups in this patient population and ensure that the right risk factors 
are targeted by our interventions and prevention programs.  
Important risk-factors for later conviction, which were over-represented in the 
ADHD sample and predictive of conviction in Study V, but were not systematically 
controlled for in the studies included in Study IV, included comorbid CD/ODD,  
parental divorce, placements outside the home, parental psychopathology, parental 
antisocial history, and a higher number of children in the household. Study V found 
that each of these factors made small but significant reductions in the estimate of how 
strongly childhood ADHD predicted the risk of conviction, as the hazard rate dropped 
from HR= 2.0 (95% CI=1.9-2.2) in the unadjusted model to HR=1.5, 95% (CI= 1.3-
1.6) in the final model. Thus, a potential consequence of a lack of statistical or 
methodological control in the studies included in Study IV could have been that some 
of the excess risk for long-term arrest, conviction, and incarceration attributed to 
ADHD could have been confounded and the risk associated with ADHD 
overestimated. This information is important, as it highlights that preventive and 
treatment initiatives targeted at this group of children and adolescents may need to 
focus broader than merely controlling symptoms of ADHD to be successful in 
buffering the long-term risk of criminality. 
Apart from the difficulties described above that makes it complex to partial out from 
the existing literature how much of the risk for criminality was specifically associated 
with ADHD, there are also critical factors that may hamper our ability to generalize 
findings from the previously conducted long-term outcome studies, to the samples of 
children and adolescents seen in the Danish psychiatric clinics today.  
First, the definition of ADHD in most of the long-term follow-up studies included in 
Study IV were based on diagnostic criteria that in many ways are different from the 
current ICD-10 criteria currently in use in Denmark. As described in background 
section 1.3, each revision of the DSM had the implication that an increasing number 
of participants were above the threshold of the diagnosis of ADHD. In addition, the 
overlap between children diagnosed with ADHD from DSM-II to DSM-III was only 
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55.4% 44, and it is likely that the DSM-II had included participants in the ADHD 
samples who would today be classified with other disorders. The consequences could 
be that the antisocial outcomes of children and adolescents diagnosed with ADHD 
during the DSM-II and DSM-III period could be worse compared to children and 
adolescents diagnosed using more recent criteria. This could be the case if the 
children from the historical cohorts either had a more severe presentation of ADHD 
or to a substantial degree were misclassified cases of for example, CD. Had more 
studies been available for analysis in Study IV, meta-regression analyses could have 
provided evidence for or against this hypothesis. This procedure would have allowed 
us to estimate the effect of the year of the diagnosis on the relative risk of arrest, 
conviction, and incarceration and perhaps explain some of the substantial 
heterogeneity identified in the meta-analysis. 
Based on the finding from Study I revealing that ADHD had increasingly been 
diagnosed during the years in which the participants included in Study II and V were 
diagnosed, one could also argue that it may have been problematic to have studied 
this cohort of children and adolescents with ADHD as an entire sample. It may be the 
case that the clinical picture in participants diagnosed with ADHD in the beginning 
of the observation period had been more complex or even more severe than in those 
who were diagnosed later on. Unfortunately, severity of ADHD was not assessed in 
the validation study (Study III) and such a potential time-effect was not assessed in 
Study II or Study V. Thus, a future study should examine whether the children and 
adolescents seen in the Danish psychiatric clinics with ADHD during the ICD-10 
period have changed with respect to the patterns of psychiatric comorbidity, social 
backgrounds etc. Such a study would provide information to which degree time and 
cohort effects might affect the potential to use results from one time-point for 
projections on the prognosis of children and adolescents seen with ADHD in the 
clinics today. 
Second, the findings from Study II and Study V also point to other domains that make 
the findings from some of the previously conducted follow-up studies difficult to 
generalise to the children and adolescents with ADHD we see in the clinics. As 
mentioned in the background chapter (see sections 1.5, 1.6), many previous studies 
conducted on children and adolescents with ADHD have systematically excluded a 
relatively large proportion of the children and adolescents that are seen at the 
psychiatric departments, namely, those with comorbid ASD, children with ID, and 
even children with an IQ just below 80. Study II identified that 18.4% of the sample 
had either ASD or ID, and in the sample of Study V 21.5 % had at least one of these 
two diagnoses. Thus, Study II and Study V underscore that a substantial proportion 
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of those children that are seen at the Danish psychiatric departments previously have 
not been followed up longitudinally on antisocial outcomes in other studies.  
This is problematic for two reasons. First, little is known about the differential 
outcomes of children with ADHD with these relatively frequent comorbid psychiatric 
diagnoses. Study V was most likely the first study to assess this constellation of 
psychiatric problems and its impact on long-term conviction. Secondly, this 
exclusion hampers the external validity of the results of the individual studies on 
which Study IV was based, as Study V provided evidence that having ADHD and 
comorbid ASD or ID significantly reduced the long-term risk of later conviction. 
Therefore studies excluding these subgroups of patients may overestimate the risk of 
long-term antisocial development for the combined group of children and adolescents 
with ADHD.   
Despite the limitations of Study IV, i.e. the studies included in this review, the overall 
finding of an association between childhood ADHD and later criminality was in 
accordance with the finding of Study V that childhood ADHD is a psychiatric 
disorder that at least for some affected individuals carries a long-term risk for 
criminal involvement. However the results of the adjusted models in Study V provide 
evidence to suggest, that the association may not be so strong as previously observed, 
and the findings highlight, that not all children and adolescents have an equal long-
term risk. Based on these findings, it seems reasonable to conclude, that it is too 
simplistic to talk about an increased risk of later criminality in children and 
adolescents with ADHD, as this excess risk is primarily experienced by a subgroup 
of these patients. 
Both Study IV and V found that on a group-level ADHD is associated with an 
increased risk of both single and repeated crime, in particular for reactive and 
impulsive crimes such as theft and violence. As an additional strength, Study V by 
extending the findings from Study IV provided evidence that ADHD is not only 
associated with a long-term risk for involvement in relatively frequently committed 
crimes, but also with the more rare and serious offenses such as rape, serious 
violence, and attempted murder. Since the regression analyses in Study V used “any 
conviction” as the outcome, it is still uncertain whether childhood ADHD per se is 
associated with the involvement in these serious types of crimes or predisposes for 
repeated criminal engagement.  
These questions should be addressed in future analyses of the dataset. Another 
important future study should address the question whether or not certain clinical 
characteristics and specific psycho-social backgrounds are particularly predictive of 
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certain kinds of crimes. A study of this kind should be carried out to further nuance 
and improve current knowledge about who is at risk for which crime and to assist in 
developing tailor-made preventive strategies. In addition, as Study V was based on 
register-data only, it will be important to conduct large follow-up studies of children 
and adolescents with ADHD that also control and estimate the effect of other 
potentially important predictors such as neuropsychological functioning and 
symptom severity, as data on such variables are not available from the Danish 
national registries, but potentially would provide us with invaluable insight. 
4.3. CLINICAL IMPLICATIONS FOR CRIME PREVENTION 
All in all the findings from Study II, the critical evaluation of Study IV, and the 
findings from Study V highlight the complexity of studying the long-term outcome 
of ADHD, and that it may not be reasonable to talk about “the outcome of ADHD” 
as such. Rather, the risk of criminality associated with childhood ADHD need to be 
assessed in more detail taking into consideration the matrix of differential risk and 
protective effects on developmental pathways that could call for different approaches 
of treating ADHD. Knowledge of this kind could ultimately improve prevention 
strategies aimed at reducing the adverse long-term outcomes experienced by children 
and adolescents with ADHD but also help to channel economic and treatment 
resources to the right population of children and adolescents. The findings indicate 
that tailoring the intervention to the specific childs needs as proposed by so-called 
personalised medicine, and taking into consideration both individuals, family and 
broader social factors may be the most viable approach if the aim is to prevent the 
long-term risk for criminality.  
Rather than looking at children and adolescents with ADHD as a homogenous group 
with the same needs, the rationale of personalised medicine models look for patient 
populations to be separated into different groups that require the individual adaption 
of clinical decisions, practices, and interventions. Personalised medicine draws on 
the philosophy from Hippocrates by highlighting that “it is more important to know 
what sort of person has a disease, than to know what sort of disease a person has” 
144.  This is meant in no way to diminish the importance of recognising and treating 
ADHD per se, but is highlighted here as an alternative approach that takes into 
consideration a broader range of factors than merely the symptoms of ADHD. 
Although the results of the studies from the present dissertation cannot specifically 
point to definitive parameters on which to subgroup children and adolescents with 
ADHD, the findings from Study II and Study V in particular, provide some 
preliminary hints about what and who should be targeted. 
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First of all, it is relevant to treat ADHD. The analyses from Study V provided 
evidence that at least short term effects of treatment with ADHD medications help to 
reduce the risk of conviction by a 20-30% rate and there was evidence to support, 
that ADHD in itself confers a long-term risk for conviction. The protective effect of 
ADHD medication was not seen when patients were treated with selective serotonin 
reuptake inhibitors (SSRI) or antipsychotics and thus support the specific efficacy of 
ADHD medication on this outcome. Study V is the second study known so far to find 
this association after it had been described before in a Swedish registry-based study  
145.   
However, the interpretation of the results from Study V are also in line with the 
conclusions from the British NICE-guidelines that ADHD in children and 
adolescents should be treated by combining pharmacological with psychosocial 
interventions 146. This approach seems most promising in the light of the results of 
Study V highlighting the heightened risk for long-term crime outcomes associated 
with comorbid CD or ODD. Treatment with stimulants is known to have some 
beneficial effects on symptoms of ODD and CD  147 but the NICE guideline clearly 
points out that a person - centered, family - based or multisystemic treatment program 
is recommended as first line treatment for the treatment of antisocial disorders 148. 
These approaches are likely to work not only by targeting symptoms of CD and ODD 
but also by addressing other risk-factors for later crimes such as the effect of parental 
antisocial involvement as identified in Study V.  Such programs may help to prevent 
crime by improving parenting skills and family functioning in socially disadvantaged 
families or families who are lacking important skills to manage their child and via 
engaging social services in the treatment program. The results of Study V underscore 
that it is critical to take into consideration not only the ADHD symptoms but also 
treat the comorbidity with CD and ODD, as well as to look at the wider family and 
social system in which the child´s life is embedded. Involvement of social services, 
employment of broader community based interventions aimed at buffering the effect 
of social deprivation on antisocial involvement in deprived neighborhoods, and 
implementation of pro-social skill development programs in institutions and schools 
may represent further constructive interventions. This understanding is important so 
that the problems associated with ADHD do not become exclusively individualised 
or thought to derive from ADHD alone. Furthermore, this approach also highlights 
that clinicians carry a high responsibility in collaboration with the wider mental 
health and social service system for ensuring a holistic and tailored service to children 
and adolescents with ADHD and their families that goes beyond only treating 
children and adolescents with ADHD using medications.  
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4.4. LIMITATIONS 
While some limitations of the studies in this dissertation have already been mentioned 
throughout the methods section and the discussion, this final section of the discussion 
will briefly sum up the limitations of the various studies of the present dissertation.  
4.4.1. STUDY I  
One limitation of Study I pertained to the issue already mentioned in the sections 
above that the DPCRR only includes information about diagnoses given at the public 
psychiatric hospitals. Thus, the numbers of patients diagnosed by privately practicing 
psychiatrists and other specialists are unknown. Thus, one has to conclude that Study 
I and other register-based studies cannot be used to provide an accurate prevalence 
or incidence estimate of the number of Danes affected by ADHD, and can only 
provide knowledge about the number of individuals who are diagnosed or treated for 
ADHD. To arrive at estimates of the prevalence of ADHD in various age and sex 
strata in the Danish population, a community based study with screening and 
interviewing of the members of the population using the diagnostic criteria of the 
ICD-10 would be needed to be carried out.  
Furthermore, since the DPCRR only started recording outpatient contacts in 1995, 
some diagnoses of ADHD predating 1995 could have been missed and erroneously 
have been recorded as incident diagnoses in the years after 1995 for participants born 
before 1995. Rather than having been excluded from the analyses, these individuals 
might have falsely inflated the findings dealing with the participants born before 
1995. However, even when considering this limitation the incidence rate of diagnosed 
ADHD was relatively low in the Danish population. Finally, it is worth mentioning 
that the diagnoses of ADHD given to children and adolescents above the age of 15 
or later than in the year 2005 have not been validated. This critique also pertains to 
the data on adults with ADHD diagnoses. 
4.4.2. STUDY II 
As Study II was based on the sub-sample of children and adolescents that were aged 
4 to 17 and diagnosed with ADHD during the years 1995 to 2010, the limitations 
described for Study I also pertain to Study II. It needs to be acknowledged that the 
heterogeneity in psychopathology observed in Study II may not be representative for 
children and adolescents with ADHD in general, for those seen outside the public 
psychiatric hospitals or for children and adolescents with unidentified ADHD, as 
clinical and community based samples may differ in terms of their clinical 
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complexity 64. This limitation is however, not considered essential for the present 
dissertation as the specific aim was to define, describe, and study the outcome of 
children and adolescents seen at the psychiatric departments in Denmark, but results 
may not fully generalise to children and adolescents with ADHD seen outside the 
public hospitals in private clinics or to participants with unidentified ADHD. Also, 
the quality of diagnoses comorbid to ADHD has not been validated. The only 
exception from this statement relates to the presence of comorbid CD and ODD in 
the participants who were diagnosed at age 4 to 15 years in the time-period 1995 to 
2005. For these participants Study III, assessed the validity of the CD/ODD diagnosis 
and found that there was an under-recognition of this comorbidity in general, but few 
false positives. A problem of under identification of a range of comorbid psychiatric 
conditions in Study II is likely, as the prevalence estimates for a range of psychiatric 
comorbidities including anxiety disorder and learning disabilities were quite low, 
compared to findings from other studies 24,62,63,70. This finding suggests that other 
comorbidities with less pronounced impact on the child’s functioning or less salience 
may have also been missed. Therefore, the findings from Study II have to be 
considered as conservative estimates.   
4.4.3. STUDY III 
As the validity of diagnoses in Study III was assessed using only medical record 
material without direct interviews or assessments of the participants or their families, 
there is a risk that the findings from Study III were affected by a confirmatory bias. 
First of all, the primary rater along with the co-raters knew that they were assessing 
medical record from participants diagnosed with ADHD. An alternative approach 
would have been to also include participants without ADHD in the validation study. 
However, such an approach would also have limitations as it is difficult to blind 
patient file material and as the assessments of patients and the patient file material 
was heavily influenced by the clinicians´ hypotheses of ADHD. For example, the 
extensive use of ADHD rating scales, the assessment of continuous performance 
difficulties, and the initiation of treatment with stimulants would likely have broken 
the blinding.   
Secondly, the primary rater had a strong personal interest in finding high validity of 
ADHD diagnoses in the DPCRR as this data would form the basis of other studies; 
this could unknowingly have biased ratings towards confirmation. Therefore, it was 
important that the records were judged by co-raters who were not using the DPCRR 
to study ADHD. The finding of high inter-rater reliability suggests that the bias did 
not substantially impact the ratings by the primary rater, but again blinding of co-
raters was only partially possible. Thirdly, a definite bias in this study relates to the 
ADHD IN DANISH CHILDREN AND ADOLESCENTS 
72
 
fact that raters only had access to evaluating medical records written by clinicians 
who suspected, assessed and finally diagnosed ADHD. Thus, evidence conflicting 
with a diagnosis of ADHD could unconsciously have been omitted from the medical 
records. This would not have been a deliberate act by those writing the medical record 
but could either way have biased findings from the validation study towards a higher 
rate of confirmation.  
An alternative approach that could have minimised the effects of a confirmatory bias 
on the results of Study III could have been to invite patients that were registered with 
a diagnosis of ADHD in the DPCRR for a diagnostic assessment of past and present 
symptoms of ADHD. This procedure was not considered for the study as it could 
have critical ethical complications. Some individuals might not have been aware of 
or remembered the fact that they as children had ever had a psychiatric assessment or 
that they had ADHD if their parents had not disclosed it to their children. In addition, 
despite the fact that retrospective assessment of symptoms of ADHD is often used 
when assessing adults referred and suspected of having ADHD, this approach also 
has limitations.  
Some studies have found only moderate correlations between reports of childhood 
ADHD and current symptoms of ADHD in interviewed adults 149,150. In the New York 
follow-up studies, individuals diagnosed with ADHD in childhood and controls were 
assessed in adulthood for their childhood symptoms of ADHD to assess the accuracy 
of the recall of symptoms 151. This study found that among those cases that had been 
diagnosed with ADHD in childhood 78% endorsed enough retrospective symptoms 
to fulfill criteria for childhood ADHD compared to 11% of the controls. The 
agreement between retrospective diagnoses made at the follow-up assessment and 
the diagnoses given in childhood was Kappa=0.67. These results suggest that while 
there is a large overlap, this method is not without its flaws. However, future 
validation studies could opt for combining patient file material with direct 
assessments of current and past symptoms of ADHD interviewing both the person 
diagnosed with ADHD and a relative.   
Finally, a limitation of this study relates to the external validity of findings. Despite 
the fact that great care went into designing the study to arrive at a reasonable sample 
size and that the validation study sample was randomly drawn from the total cohort, 
it is unclear whether the findings from the validation study can truly generalise to the 
total sample. In addition, as the study only assessed children and adolescents 
diagnosed from 1995 to 2005, the validity of diagnoses given later or to older 
participants remains unclear. The findings from Study I revealed that for each year 
in the study period an increased number of participants were diagnosed with ADHD 
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across all age and sex-strata. Thus, it is important to assess the validity of diagnoses 
given after 2005 in the DPCRR to ensure that the high-quality assessment observed 
in Study III is still carried out. Unfortunately, in recent years the Danish psychiatric 
departments have also been subjected to an increasing political and administrative 
pressure to ensure that waiting lists are cut back and that more patients are seen 
without expanding the services. Clinicians are more pressured to ensure that 
diagnoses are given faster than ever before as a consequence. These changes could 
have deleterious effects but the concern needs to be addressed empirically. 
4.4.4. STUDY IV 
Study IV differed from the remaining empirical studies in this dissertation as it was 
a systematic review and meta-analysis. As the purpose of the this study was to inform 
the design of Study V, the review and meta-analysis focused solely on studies that 
had employed a design similar to what was possible to mimic in Study V. Therefore, 
the study only focused on studies that had assessed the long-term crime risk 
associated with childhood ADHD using official sources of data to report on the 
outcomes. Thus, this study did not assess risk of involvement in self-reported crime 
or scores on antisocial behaviour scales. A focus only on data from official crime 
registries or documents can only capture the types of antisocial behaviour that come 
to the attention of law-enforcement agencies and thus, may only cover the “tip of the 
iceberg” 110. Despite this narrow focus, the fact that the results are not affected by the 
biases that arise when using self-reports, such as exaggeration or under-reporting 110, 
is advantageous. In addition, as Study IV assessed the relative risk rather than 
estimated the prevalence of antisocial involvement, this bias should only have 
affected the findings if either individuals with childhood ADHD or controls had had 
an elevated risk of getting caught for their offenses.  
Another limitation of Study IV relates to the methods used. In the study only one 
author was responsible for the selection of studies, increasing the risk of missing or 
leaving out studies by accident. To minimise the risk of overlooking studies, literature 
lists of included studies were back-searched, however; it is not certain whether or not 
relevant studies may have been missed. However, the publication bias analyses 
revealed that the results were robust and that more than 40 studies had to have been 
missed or unidentified in the search to change the findings to a null-finding. Finally, 
due to the relatively small number of studies identified for the three primary outcomes 
of arrests, convictions, and incarcerations, too few studies existed to explore the 
sources of heterogeneity that were present in the study on the risk of arrests and 
convictions.  
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4.4.5. STUDY V 
As Study V was the first among the three registry-based studies in this dissertation 
that was based on a sample for which ADHD diagnoses were validated, there is some 
certainty that the rate of misclassification among the exposed was relatively low. 
However, as there were no measures ascertaining whether cases classified as non-
affected could be taken, the risk of misclassification of the non-affected status is 
unknown. However, as the participants were randomly drawn from the general 
population and based on what is known about the prevalence of ADHD in this age-
group, the rate of misclassification should not exceed some 5-10%. At best, the 
misclassification of this kind would tend to underestimate the risk of criminality 
associated with ADHD.  
 
Secondly, and related to the findings from Study III it is likely that for example, 
misclassification of ODD/CD status among the child and adolescent cohort occurred. 
Such misclassification could both result in under- and overestimation of the effect of 
these variables on outcome. Thirdly, as the findings from Study I were suggestive of 
many years of overlooking ADHD in the population of adults in the time-period from 
1995 to 2010, parental ADHD and psychiatric status could have been misclassified. 
Therefore, as adult ADHD is associated with adult social disadvantage, the effect of 
psychosocial adversity (e.g. low income, low educational status, antisocial 
involvement) on long-term conviction rates may have been overestimated if these 
were indirect measures of unidentified parental ADHD.  Fourthly, a limitation of 
Study V was that many of the participants included in the analysis had not yet lived 
through all their years at risk for antisocial involvement and thus, later follow-up 
analyses of this cohort may find that estimates will change as the individuals of this 
sample grow older. Fifth and finally, as Study V was based only on register data, the 
effect of other measures such as neuropsychological test-performance, personality 
traits or symptoms severity could not be estimated nor controlled for. This is 
unfortunate because information on such variables may have improved our 
knowledge about risk-factors but also protective factors even more than was the case 
in Study V.  
  
CHAPTER 5. CONCLUSION 
The purpose of this dissertation was to assess how often ADHD has been diagnosed 
in Denmark in the ICD-10 period and to identify underlying time trends. In addition, 
the dissertation aimed at describing the socio-demographic and clinical 
characteristics of Danish children and adolescents with ADHD, to assess their long-
term risk for crimes, and to analyze whether any characteristics of the children and 
their families during childhood and adolescence were predictive for later crimes.  
Study I found that since the introduction of ICD-10 in Denmark in 1995, diagnoses 
of ADHD in the Danish population increased. This trend was more pronounced 
among adolescents, adults, and females. Despite these observed increases, there was 
no direct evidence to support the conclusion that this trend was caused by either over-
diagnosis or an increase in the amount of individuals in the population developing 
ADHD. It is more likely, that the time trends were related to increased knowledge, 
awareness, and recognition of ADHD and mental disorders in general. The results of 
Study III also provided evidence that at least the diagnoses of ADHD given to 
children and adolescents during the years 1995 to 2005 in Danish psychiatric 
hospitals had a good overall validity, although the diagnoses of the subtypes of 
ADHD as diagnosed in the ICD-10 were less valid.  
The results of Study II and Study IV did however, support that children and 
adolescents with ADHD do not constitute a homogenous group of patients. Rather, 
these patients often have other comorbid psychiatric problems, more often come from 
socially disadvantaged homes, and overall tend to have an aggregation of risk factors 
known to affect the long-term developmental outcome of children and adolescents. 
Study IV provided an overview of the previously published studies assessing the 
long-term risk associated with ADHD for having an official arrest, conviction or 
incarceration record and it was estimated that ADHD in childhood leads to a two to 
threefold increased risk of these outcomes.  
In Study V, the aim was to replicate and extend these findings in a large, nationwide 
cohort of children and adolescents diagnosed with ADHD at the Danish psychiatric 
departments. This study allowed for the analysis of rigorously controlled models of 
the aggregation of risk factors in this patient population to an extent that had not been 
possible in most of the previous studies due to small sample-sizes. Even in adjusted 
models, ADHD in childhood was associated with an increased risk of long-term 
conviction. However, the results also revealed that not only ADHD but also comorbid 
CD/ODD, low SES, parental psychopathology, and parental antisocial involvement 
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were significant risk factors, that need to be targeted if later crime development in 
children and adolescents with ADHD should be prevented successfully.  
Therefore, it was concluded that it may not be reasonable to talk about “the outcome 
of ADHD” as such but rather, that clinicians and other professionals in their attempts 
of treating children and adolescents with ADHD and their families need to give equal 
weight to assessing and intervening with comorbid conditions and social risk-factors. 
Only by a patient-oriented rather than a diagnosis-focused approach to treatment will 
the intervention efforts be likely to succeed. Future analyses of the Danish register 
data and further longitudinal studies, including other sources of data than is contained 
in the registries should aim to improve our knowledge about how the various risk and 
protective factors interact and how individuals with ADHD are likely to develop. As 
complex problems are likely to be solved only by complex solutions, we need to study 
this complexity and reach a better understanding of ways to change or positively 
impact on the developmental trajectories of at-risk children and adolescents.  
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The most frequent reason for referral to the child and adolescent psychiatric 
hospitals in Denmark is the suspicion that a child or an adolescent may have 
Attention-Deficit/Hyperactivity Disorder (ADHD). The purpose of this dis-
sertation was to assess how often ADHD has been diagnosed in Denmark, 
to assess the validity of the ADHD diagnoses given to children and ado-
lescents, to describe the socio-demographic and clinical characteristics of 
Danish children and adolescents with ADHD, and to assess their long-term 
risk for crimes.
In the years under investigation, the incidence rates of diagnosed ADHD had 
significantly increased and the majority of ADHD diagnoses given to chil-
dren and adolescents could be confirmed and were given based on high-qual-
ity clinical assessments. Results supported that children and adolescents with 
ADHD constitute a heterogeneous group that often have comorbid psychiat-
ric problems, and overall tend to have an aggregation of risk factors for crim-
inality. Both the meta-analysis and analyses of the Danish data confirmed, 
that childhood ADHD increases the risk of long-term criminality. Not only 
ADHD but also comorbidity, low socio-economic status, parental psycho-
pathology, and parental antisocial involvement were among significant risk 
factors for criminality and therefore a patient and family-oriented approach 
to treatment and prevention is warranted.
